bupropion and varenicline

bupropion has been researched along with varenicline in 410 studies

Research

Studies (410)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's86 (20.98)29.6817
2010's250 (60.98)24.3611
2020's74 (18.05)2.80

Authors

AuthorsStudies
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Caldarone, BJ; Eaton, JB; Kozikowski, AP; Lukas, RJ; Yu, LF; Zhang, HK1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Camarelles Guillem, F1
Corelli, RL; Hudmon, KS1
Azoulay, S; Billing, CB; Gong, J; Gonzales, D; Nides, M; Oncken, C; Reeves, KR; Rennard, SI; Watsky, EJ; Williams, KE1
Azoulay, S; Billing, CB; Gong, J; Hays, JT; Jorenby, DE; Reeves, KR; Rigotti, NA; Watsky, EJ; Williams, KE1
Johnson, KC; Klesges, RC; Somes, G1
Keating, GM; Siddiqui, MA1
Dimoulas, P; Mills, EJ; Wilson, K; Wu, P1
Siu, EC; Tyndale, RF1
Bullen, C; Fagerström, K; McRobbie, H; Whittaker, R1
Frishman, WH1
Evans, SE; Leischow, S; Nides, M; Sarna, L1
Oberpichler-Schwenk, H1
Martini, B1
Bornstein, MM; Klingler, K; Ramseier, CA; Saxer, UP; Walter, C1
Brixner, D; Dirani, R; Jackson, KC; Nahoopii, R; Said, Q1
Vandemergel, X1
Crane, R1
Pipe, AL; Quinlan, B; Reid, RD; Riley, DL1
Hering, T4
Croghan, E1
Coffay, AO1
O'Brien, CP2
Lerman, C; Patterson, F; Schnoll, RA1
Doggrell, SA1
Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P1
George, TP; Le Foll, B1
Andrews, JO; Bennett, SM; Heath, JH1
Cahill, K; Lancaster, T; Stead, L2
Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R1
Cooley, ME; Murphy, M; Sarna, L; Sipples, RL1
Bolin, K; Lindgren, B; Mörk, AC; Willers, S1
Benowitz, NL2
Asch, DA; Heitjan, DF; Lerman, C; Patterson, F; Ray, R; Rukstalis, M1
Tyndale, R1
Crawford, JT; Goldenberg, RL; Tolosa, JE1
Baker, C; Boler, A; Howard, P; Knight, C1
Bölcskei, PL; Walden, K1
Tønnesen, P2
Bélisle, P; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; Mottillo, S; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S; Yavin, D1
Cahill, K; Lancaster, T; Stead, LF4
Aveyard, P1
Ferguson, SG; Shiffman, S1
Delva, NJ1
Bader, P; McDonald, P; Selby, P1
Schunack, W1
Brace, V; Danielian, P; Rore, C; Williams, D1
Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G1
Rose, JE1
Galanti, LM1
Carrozzi, L; Pistelli, F; Viegi, G1
Schroeder, SA1
McEwen, A; West, R1
Florek, E; Piekoszewski, W1
Groman, E; Homaier, I; Lichtenschopf, A; Tschabitscher, P1
Arora, G; Jain, M; Talwar, A1
Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR; Sood, A1
Ferguson, SG; Gritz, ER; Henningfield, JE; Shiffman, S1
Silva, RR1
Dugan, SE; Garrison, GD1
Cryan, JF; Flynn, RA; Glynn, DA; Kennedy, MP; Kent, P1
Laniado-Laborín, R2
George, TP; Lising-Enriquez, K1
Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL1
Heimlich, L; Steinberg, ML; Williams, JM1
Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T1
Keiding, H1
Elia, D; Giucastro, G; Marangio, E; Mariano, ME; Olivieri, D; Scarascia, A; Tzani, P1
Maritz, GS1
Kuehn, BM1
Annemans, L; Bartsch, P; Marbaix, S; Nackaerts, K; Prignot, J1
Kranzler, HR; Oncken, CA1
Tonstad, S1
Davies, C; Gunnell, D; Irvine, D; Martin, RM; Wise, L1
Hind, D; Kenjegalieva, K; Peters, J; Tappenden, P1
Lavigne, JE1
Batra, A; Friederich, HM1
Hao, W; Tan, L; Tang, Q1
Jormanainen, V; Kotomäki, T; Linden, K; Linna, M; Sintonen, H; Wilson, K1
Corelli, RL; Hudmon, KS; Prokhorov, AV1
Keating, GM; Lyseng-Williamson, KA1
Drach, L; Fox, V; Holbert, T; Maher, J; Saddler, LC; Schubert, S1
Ainamo, A; Binnie, VI; Carr, AB; Fundak, A; Koeber, A; Koerber, A; Needleman, IG; Ohrn, K; Rosseel, J1
Hays, JT; Lawrence, D; Lee, TC; Leischow, SJ1
Bhat, A; Crain, D1
Ioannides-Demos, LL; McNeil, JJ; Piccenna, L1
Herman, AI; Sofuoglu, M1
Ruff, P1
Zeller, A1
von Garnier, C1
Arteaga, C; Brandon, TH; Gonzales, D; Jorenby, DE; Lee, TC1
Baker, CL; Bushmakin, AG; Cappelleri, JC; Croghan, IT; Hays, JT1
Bover, MT; Foulds, J; Richardson, DL; Schmelzer, AC; Steinberg, MB; Williams, JM1
Johnson, TS1
Cesario, A; Galetta, D; Granone, P; Greenberg, DS; Margaritora, S; Russo, P; Rutella, S; Spaggiari, L; Veronesi, G1
Ebbert, JO; Hays, JT1
Balmford, J; Borland, R; Cummings, KM; Hammond, D1
Allan, GM; Els, C; Ivers, N1
Weinsier, ST1
Al Rubaiy, SA; Bloom, SA; Guendisch, D; Papke, RL; Trocmé-Thibierge, C1
Ebbert, J; Erwin, PJ; Montori, VM; Stead, LF1
Grief, SN1
Díaz Cerezo, S; Martí Sánchez, B; Navarro Artieda, R; Sanz De Burgoa, V; Sicras Mainar, A1
Coleman, T; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L1
Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Severson, HH1
Simon, JA1
Aubin, HJ; Karila, L; Reynaud, M1
Fidler, JA; Kotz, D; West, R1
Agboola, S; Coleman, T; Leonardi-Bee, J; McNeill, A; Taylor, M1
Coleman, T; Lewis, S; McNeill, A; Szatkowski, L1
Beebe, LA; Choi, WS; Cully, L; Daley, CM; Faseru, B; Greiner, AK; Kaur, B; Shireman, TI; Talawyma, M; Yeh, HW1
Belcon, AL1
Marti, J1
Carpenter, MJ; Gray, KM; Klintworth, EM; Lewis, AL; Upadhyaya, HP1
Barendregt, JJ; Higashi, H1
Ashare, RL; McKee, SA1
Baker, TB; Fiore, MC1
Benowitz, NL; Bierut, LJ; Conti, DV; Kaprio, J; King, DP; Lerman, C; Paciga, S; Park, PW; Pickering, E1
Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S1
Fidler, J; Kotz, D; West, R1
Lockhart, I; Mardle, T; Merrett, S; Percival, F; Wright, J1
Coleman, T; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L1
Ammerman, S; Bailey, SR; Crew, EE; Killen, JD; Riske, EC; Robinson, TN1
Coleman, CI; Mahmoudi, M; Sobieraj, DM1
Schuurmans, MM; Zellweger, JP1
Cuesta, G; Lovato, P; Lutz, MA2
Etter, JF; Schneider, NG1
Larzelere, MM; Williams, DE1
Ju, W; Jung, HS; Kim, H; Myung, SK; Oh, SW; Park, CH; Seo, H1
Coster, TS; Graham, DJ; Meyer, TE; Moeny, D; Mosholder, AD; Ouellet-Hellstrom, RP; Taylor, LG; Williams, JR; Xie, S1
Athanasakis, K; Igoumenidis, M; Karampli, E; Kyriopoulos, J; Sykara, G; Vitsou, E1
Ebbert, JO; Lockhart, I; Mills, EJ; Puhan, M; Thorlund, K; Wu, P1
Duaso, M; Duncan, D1
Bansal-Travers, M; Borland, R; Cummings, KM; Fix, BV; Fong, GT; Hammond, D; Hyland, AJ; Kasza, KA; McNeill, AD1
Holloway, AC; Nicholson, CJ; Raha, S; Woynillowicz, AK1
Brown, VL; Cinciripini, PM; Cui, Y; Dani, JA; Engelmann, JM; Karam-Hage, M; Kosten, TR; Lam, CY; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW1
Cesario, A; Granone, P; Lococo, F; Petracca-Ciavarella, L; Russo, P1
Rigotti, NA1
Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D1
Abe, TO; Issa, JS; Moura, S; Pereira, AC; Santos, PC1
Dautzenberg, B1
Hviid, A; Pasternak, B; Svanström, H2
Caudill, C; Dumire, W; Lewis, A; Morgan, SK1
Almgren, MM; Clark, KJ; Stroman, RT; Wynn, WP1
Lancaster, T; Stead, LF1
Camarelles Guillem, F; Clemente Jiménez, L; Dalmau González-Gallarza, R; Díaz-Maroto Muñoz, JL; Lozano Polo, A; Pinet Ogué, MC1
Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, S; Javitz, HS; Krasnow, R; Kwok, PY; Lee, W; Lerman, C; Liu, J; Michel, M; Nishita, D; Swan, GE; Tyndale, RF1
Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C1
Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I1
Porwal, M; Tsoi, DT; Webster, AC1
Aubin, HJ; Berlin, I; Luquiens, A1
Brose, LS; Stapleton, JA; West, R1
Fatemi, SH; Folsom, TD; Kneeland, RE; Liesch, SB; Thuras, PD; Yousefi, MK1
Baker, MA; Brown, JS; Kornegay, C; Platt, R; Toh, S1
Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW1
Bölcskei, PL; Davis-Wagner, P; Grundnig, J; Pommer, P1
Behm, FM; Rose, JE3
Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S1
Cahill, K; Lancaster, T; Perera, R; Stevens, S1
Abella, F; Baena, A; Banque, M; Bullon, R; Carreras, JM; Comino, A; Jimenez-Muro, A; Marqueta, A; Masuet-Aumatell, C; Morchon, S; Nerin, I; Pinet, C; Ramon, JM; Vilarasau, A1
Fagerström, KO; Jiménez-Ruiz, CA1
Getsios, D; Ishak, KJ; Marton, JP; Revankar, N; Rublee, D; Ward, AJ; Willke, RJ; Xenakis, JG1
Acuña, M; Bertoglia, MP; Bustamante, P; Cavada, G; Navarrete, S; Peña, P; Suárez, C; Zagolin, M1
Brose, L; Brown, J; Herbec, A; Raupach, T; West, R1
Aubin, HJ; Le Houezec, J1
Trivedi, D1
Clair, C; Rigotti, NA1
Gibbons, RD; Mann, JJ1
Boomershine, V; Haber, SL; Raney, E1
Davies, NM; Gunnell, D; Martin, RM; Metcalfe, C; Thomas, KH; Windmeijer, F1
Checa-Andrés, MD; Esparza-Martín, N; García-Cantón, C; Guerra-Rodríguez, R; Ramírez-Puga, A; Suria-González, S1
Lerman, C; Perkins, KA1
Eapen, S; Mills, EJ; Prochaska, JJ; Thorlund, K; Wu, P1
Bobes, J; Diaz-Mesa, E; Elizagarate, E; Galvan, G; Garcia-Alvarez, L; Garcia-Blanco, J; Garcia-Portilla, MP; Saiz, PA; Sarramea, F1
Brown, J; Kotz, D; West, R1
Allen, SS; Croghan, IT; Ebbert, JO; Hatsukami, DK; Hays, JT; Hurt, RD; Schroeder, DR1
Gupta, T; Jain, R; Majumder, P1
Cieślewicz, A; Jabłecka, A; Korzeniowska, K1
Daughton, DM; Rennard, SI1
Fahrenwald, NL; Kerkvliet, JL1
Anderson, P; Johnson, M; Lockhart, I1
Ebbert, JO; Elrashidi, MY1
Amos, A; Ludbrook, A; McConville, S; Ormston, R; van der Pol, M1
Arteaga, C; Brosky, G; Oh, P; Ranger, S; Raymond, V; Selby, P1
Mendelsohn, CP; Richmond, RL; Zwar, NA1
Rausch, R1
Cahill, K; Hartmann-Boyce, J; Lancaster, T; Stead, LF1
By, K; Graham, DJ; Kelman, JA; Kornegay, C; Levenson, M; MaCurdy, TE; McKean, S; Mosholder, A; Racoosin, JA; Worrall, C; Young, J1
Kotz, D; Sheikh, A; Simpson, C; van Schayck, OC; Viechtbauer, W; West, R2
Fisher, DC; Fletcher, PJ; Guy, EG; Higgins, GA1
Ditre, JW; Farris, SG; Leventhal, AM; Schmidt, NB; Zvolensky, MJ1
Barra, NG; De Long, NE; Hardy, DB; Holloway, AC1
Brown, J; Ferguson, SG; Frandsen, M; West, R1
Arbab-Zadeh, A; Garg, J; Krishnamoorthy, P; Lavie, CJ; Lichstein, E; Sharma, A; Sochor, O; Thakar, S1
Ballbè, M; Cabezas, C; Fernández, E; Gual, A; Martínez, C; Riccobene, A; Saltó, E; Valverde, A1
Akdağ, R; Buzgan, T; Çelik, İ; Erman, M; Hayran, M; Irmak, H; Kılıçkap, S; Tosun, N; Tuncer, M; Yüce, D1
Broughton, AD; Hylick, EV; Smalls, TD; Woodard, TJ1
Ebbert, JO; Elrashidi, MY; Hong, AS; Schroeder, DR1
Hergel, LL; Nielsen, G; Poulsen, PB; Ringbæk, T; Spillemose, H; Strand, M; Wedell-Wedellsborg, D1
Hall, BJ; Levin, ED; Rose, JE; Slade, S; Wells, C1
van Boven, JF; Vemer, P1
Aveyard, P; Farley, A; Hollands, GJ; Lindson-Hawley, N; McDermott, MS; Vogt, F1
Boffi, R; Marabelli, C; Munarini, E; Pozzi, P1
Abe, TO; Gaya, PV; Issa, JS; Krieger, JE; Pereira, AC; Santos, JR; Santos, PC; Tomaz, PR1
Borse, MS; Brown, JD; Li, C; Shewale, AR1
Borland, R; Maddox, S; Segan, CJ1
Burkholder, GA; Clark, CB; Cropsey, KL; Jardin, BF; Raper, JL; Saag, MS1
Azrin, ST; Baller, J; Daumit, GL; Juliano-Bult, D; McGinty, EE1
Knudsen, HK; Roman, PM1
Cummins, SE; Gamst, AC; Ikeda, T; Wong, S; Zhu, SH1
He, Y; Sun, S; Wu, L; Zeng, J1
Benowitz, NL; Prochaska, JJ1
Fortmann, SP; Henderson, JT; Patnode, CD; Senger, CA; Thompson, JH; Whitlock, EP1
Siu, AL1
Miller, ME; Tidey, JW1
Baydur, H; Budak, R; Choussein, B; Doğanay, S; Ergör, G; Günay, T; Pekel, Ö1
Hussain, S; Selby, P; Voci, S; Zawertailo, L1
Altet-Gomez, N; Barrueco, M; de Higes-Martinez, E; Granda-Orive, JI; Jiménez-Ruiz, CA; Lorza-Blasco, JJ; Oyagüez, I; Rejas, J; Riesco-Miranda, JA; Signes-Costa, J; Solano-Reina, S1
Koilpillai, P; Lancaster, T; Stead, LF1
Cather, C; Evins, AE1
Ebbert, JO; Elrashidi, MY; Stead, LF1
Eden Evins, A; McNeill, A; Roberts, E; Robson, D1
Abughosh, SM; Chen, H; Essien, EJ; Johnson, ML; Peters, RJ; Wu, IH; Yang, M1
Davies, GA; Leung, LW1
Au, DH; Collins, MP; Feemster, LC; Melzer, AC1
Chamberlain, C; Coleman, T; Cooper, SE; Davey, MA; Leonardi-Bee, J1
Ebbert, JO; Little, MA1
Abe, TO; Gaya, PV; Pereira, AC; Pinheiro, GG; Santos, PC; Scholz, J; Silva, AP1
Seguí Díaz, M1
Evoy, KE; McClain, C; Vogeler, T1
Brose, LS; McEwen, A1
Bahadir, A; Bakan, ND; Iliaz, S; Ortakoylu, MG; Yazar, E; Yurt, S1
Banks, ML; Blough, BE; Smith, DA1
Aveyard, P; Hartmann-Boyce, J1
Prochaska, JJ1
Abughosh, S; Chen, H; Essien, EJ; Johnson, ML; Peters, RJ; Wang, X; Yang, M1
Aumann, I; Hagemann, N; Treskova, M; von der Schulenburg, JM1
Hyon Baik, S; Jarlenski, M; Zhang, Y1
Anthenelli, RM; Ascher, J; Benowitz, NL; Evins, AE; Krishen, A; Lawrence, D; McRae, T; Russ, C; St Aubin, L; West, R1
Zawertailo, L1
Cahill, K; Fanshawe, TR; Lancaster, T; Lindson-Hawley, N; Thomas, KH1
Abe, TO; Amorim, C; Buzo, CG; Gaya, PV; Lopes, NH; Pereira, AC; Pierri, H; Santos, PC; Scholz, J1
Blazekovic, S; Brubaker, TR; Hitsman, B; Hole, A; Kalhan, R; Langer, C; Leone, F; Patel, J; Price, S; Schnoll, R; Veluz-Wilkins, A; Wileyto, EP1
Klein, JW1
Ban, N; Hamajima, N; Hasegawa, Y; Murohara, T; Oguri, T; Okada, Y; Sato, M; Shimadu, S1
Ojo, O; Temitayo Orisasami, I1
Kotz, D; van der Meer, RM; van Eerd, EA; van Schayck, OC1
Aitken, D; Mullen, KA; Pipe, AL; Pritchard, G; Reid, RD; Walker, K1
Gass, JC; Germeroth, LJ; Hawk, LW; Moore, FE; Motschman, CA; Munoz, DA; Rhodes, JD; Schlienz, NJ; Tiffany, ST; Wray, JM1
Muheim, L1
Burkholder, G; Cropsey, KL; McClernon, FJ; Mugavero, MJ; O'Cleirigh, C; Valera, P; Willig, J1
Cristóbal Fernández, M; de Granda Orive, JI; de Higes Martinez, E; Garcia Rueda, M; Jiménez Ruiz, CA; Lorza Blasco, JJ; Pascual Lledó, JF; Riesco Miranda, JA; Signes Costa-Miñana, J; Solano Reina, S; Valencia Azcona, B; Villar Laguna, C1
Eberg, M; Eisenberg, MJ; Filion, KB; Gore, GC; Grad, R; Joseph, L; Larivière, J; Reynier, PM; Suissa, K1
Cinciripini, PM; Engelmann, JM; Green, CE; Karam-Hage, M; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW1
Bagci, BA; Bahadir, A; Chousein, EGU; Hattatoglu, DG; Iliaz, S; Ortakoylu, MG; Tanriverdi, E; Tural Onur, S; Uysal, MA; Yurt, S1
Jacobson, LT; Richter, KP; Scheuermann, TS; Shireman, TI1
Kotz, D; Sheikh, A; Simpson, CR; van Schayck, OCP; Viechtbauer, W; West, R1
Baraona, LK; Daniels, JL; Lovelace, D; McDaniel, L1
Acuña Izcaray, A; Alfageme Michavila, I; Buljubasich, D; Casas, A; Chatkin, JM; de Granda Orive, JI; Guerreros Benavides, A; Jiménez Ruiz, CA; Noé, V; Núñez-Sánchez, I; Paez Espinel, N; Palomar Lever, A; Riesco Miranda, JA; Sánchez-Angarita, E; Sansores, RH; Zabert, G1
Galanti, MR; Hansson, J; Janszky, I; Möller, J; Monárrez-Espino, J; Söderberg-Löfdal, K1
Sambamoorthi, U; Shah, A; Shah, D; Tan, X1
Auer, R; Cardinaux, R; Cornuz, J; Jacot Sadowski, I; Jakob, J; Selby, K1
Brabyn, S; Cook, L; Gilbody, S; Peckham, E; Tew, G1
Gulati, M; Hellkamp, A; Pagidipati, NJ; Peterson, ED; Thomas, L; Wang, TY1
Bruguera, E; Cedillo, S; Rejas-Gutiérrez, J1
Carroll, M; de Andrade, D; Kinner, SA; Puljević, C; Spittal, MJ1
Kress, CM; Obi, NU; Prochazka, AV1
An, H; He, Y; Jiang, B; Liu, Q; Wu, L; Zhang, L; Zhou, C; Zuo, F1
Boffi, R; Colombo, F; Galvan, A; Noci, S; Pasetti, G; Pastorino, U; Pintarelli, G; Pozzi, P; Sala, F1
Cinciripini, PM; Cui, Y; Deweese, MM; Engelmann, JM; Green, CE; Karam-Hage, M; Lam, CY; Minnix, JA; Robinson, JD; Stevens, EM; Versace, F; Wetter, DW1
Cinciripini, PM; Cui, Y; Engelmann, JM; Karam-Hage, M; Lam, CY; Minnix, JA; Robinson, JD; Xian, J1
Latimer, KM1
Freedman, LS; Galili, T; Goodman, M; Kott, J; Rosen, LJ1
Anthenelli, RM; Benowitz, NL; Evins, AE; Krishen, A; Lawrence, D; Maravic, MC; McRae, T; Russ, C; St Aubin, L; West, R1
Eisenberg, MJ; Filion, KB; Franck, C1
Coleman, T; Jones, M; Turner, E; Vaz, LR1
Jordan, CJ; Xi, ZX1
Anthenelli, RM; Benowitz, NL; Hays, JT; Lawrence, D; McRae, T; Pipe, A; St Aubin, L; Tonstad, S; West, R1
Abdul-Kader, J; Airagnes, G; D'almeida, S; Le Faou, AL; Limosin, F1
Bambs S, C; Cerda L, J; Corvalán B, MP; Pavié G, J; Véjar M, L; Zagolin B, M1
Kathuria, H; Leone, FT; Neptune, ER1
Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Underner, M1
Clark, AJ; Johnsen, SP; Lange, P; Thomsen, RW; Tøttenborg, SS1
Aveyard, P; Coleman, T; Hajek, P; Lewis, S; Lindson, N; Munafo, M1
Bozinoff, N; Le Foll, B1
Bondy, SJ; Chaiton, M; Cohen, JE; Diemert, LM; Ferrence, RG; Fung, MD; Zhang, BR1
Hollenbeak, CS; Kulaylat, AS; Soybel, DI1
Barboza, J1
Hughes, JR; Klemperer, EM; Naud, S1
El-Mallakh, P; Okoli, CTC; Seng, S1
Achenbach, C; Akanbi, MO; Bilaver, LA; Carroll, AJ; Hitsman, B; Jordan, N; McHugh, MC; Murphy, R; O'Dwyer, LC1
Benowitz, NL; Kalkhoran, S; Rigotti, NA1
Charntikov, S; Kazan, T1
Brown, J; Jackson, SE; McGowan, JA; Proudfoot, H; Shahab, L; Ubhi, HK; West, R1
Leischow, SJ1
Bennett, DA; Bergen, AW; David, SP; Munafò, MR; Panagiotou, OA; Schuit, E1
Hajek, P; Hartmann-Boyce, J; Jarvis, M; Livingstone-Banks, J; Norris, E; West, R1
García-Gómez, L; Hernández-Pérez, A; Jiménez-Ruiz, C; Noé-Díaz, V; Riesco-Miranda, JA1
Anthenelli, RM; Benowitz, NL; Evins, AE; Gaffney, M; Krishen, A; Lawrence, D; McRae, T; Russ, C; St Aubin, L; West, R1
Baker, TB; Bierut, LJ; Chen, LS; Culverhouse, RC; Ma, Y; Piper, ME; Saccone, NL1
Barnett, PG; Duffy, SA; Essenmacher, CA; Geraci, MC; Hall, SV; Ignacio, RV; Kim, HM; Sherman, SE1
Brath, H; Fasching, P; Kaser, S; Tatschl, C1
Brown, J; Jackson, SE; Kotz, D; West, R1
Brousse, G; de Chazeron, I; Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Schmitt, A; Underner, M1
Fanshawe, TR; Hartmann-Boyce, J; Hong, B; Livingstone-Banks, J; Wheat, H1
Anthenelli, RM; Aubin, LS; Ayers, CR; Evins, AE; Heffner, JL; Krishen, A; Lawrence, D; McRae, T; Russ, C; West, R1
Guichenez, P; Perriot, J; Underner, M1
Cornuz, J; Jacot Sadowski, I; Rat, C; Selby, K1
Choi, J; Jo, MW; Paek, YJ; Seo, YG1
Gendy, MNS; Ibrahim, C; Le Foll, B; Sloan, ME1
Adermark, L; Danielsson, K; de Bejczy, A; Ericson, M; Söderpalm, B1
Eberg, M; Filion, KB; Platt, RW; Reynier, P1
Xia, S; Zhao, S; Zhao, Y; Zhong, Z1
Havard, A; Kennedy, D; Lee, ML; Tran, DT; Welsh, A1
George, TP; Kozak, K1
Alebshehy, R; AlMulla, A; El-Awa, F; Fraser, CP; Fu, D; Hassan-Yassoub, N; Ismail, M1
Bassett, K; Carney, G; Dormuth, CR; Maclure, M; Taylor, S1
Charntikov, S; Cova, N; Kazan, T; Madore, VM; Robison, CL1
Abney, LR; Adams, DW; Beaulieu, DB; Freiberg, MS; Gatskie, V; Gurwara, S; Horst, SN; King, S; Peyton, SC; Pointer, SO; Schwartz, DA; Scoville, EA; Tindle, HA; Wells, QS1
Hartmann-Boyce, J; Hong, B; Howes, S; Lindson, N; Livingstone-Banks, J1
Elkind, MSV; Kamel, H; Parikh, NS; Salehi Omran, S; Willey, JZ1
Mathieson, K; Olawuyi, O1
Jiang, Y; Kuang, D; Xiao, L; Xie, L; Yang, Y1
Filipponi, A; Giordano, P; Giulietti, F; Iacoacci, C; Rosettani, G; Sarzani, R; Spannella, F1
Kenny, PJ; O'Brien, CP; Pierce, RC; Swinford-Jackson, SE; Unterwald, EM; Vanderschuren, LJMJ1
Cruz-Lopes, L; Eakin, MN; Evers-Casey, S; Evins, AE; Farber, HJ; Fathi, J; Fennig, K; Folan, P; Fulone, I; Galiatsatos, P; Gogineni, H; Kantrow, S; Kathuria, H; Lamphere, T; Leone, FT; Murray, RL; Neptune, E; O'Brien, KK; Pacheco, MC; Pakhale, S; Pavalagantharajah, S; Prezant, D; Ross, S; Sachs, DPL; Toll, B; Upson, D; Xiao, D; Zhang, Y; Zhu, M1
George, O; Smith, LC1
Firth, J; Kisely, S; Siskind, DJ; Wong, TT; Wu, BT1
Benipal, S; Bilimoria, K; Budhram, DR; Persaud, N; Wang, R; Woods, H1
Borderud, S; Cooley, ME; de León-Sanchez, S; Friedman, ER; Gonzalez, I; Holland, S; Hyland, KA; Irwin, KE; Kwon, D; Levy, DE; Malloy, L; Miller-Sobel, J; Muzikansky, A; O'Brien, M; Ostroff, JS; Park, ER; Partridge, AH; Perez, GK; Peterson, L; Pirl, WF; Ponzani, C; Rabin, J; Regan, S; Rigotti, NA; Sprunck, K; Temel, JS; Whitlock, CW1
Anthenelli, RM; Benowitz, NL; Evins, AE; Heffner, JL; Lawrence, D; Maravic, MC; McRae, T; Russ, C; West, R1
Davies, NM; Douglas, I; Gunnell, D; Martin, RM; Taylor, AE; Taylor, GMJ; Thomas, KH1
Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC1
Ahluwalia, JS; Benowitz, NL; Lawrence, D; Nollen, NL; Okuyemi, K; Samuels, L; Sanderson Cox, L1
Bonevski, B; Walker, N1
Anthenelli, RM; Correa, JB; Doran, N; Dubrava, S; Gaznick, N; Lawrence, D; McKenna, BS; Saccone, PA1
Anthenelli, RM; Aubin, LS; Beard, E; Benowitz, NL; Evins, AE; Jackson, SE; Krishen, A; Lawrence, D; McRae, T; Russ, C; West, R1
Boezen, HM; Bos, JH; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B1
Dutro, MP; Ebbert, J; Fisher, M; Hays, JT; Jimenez-Ruiz, C; Li, J1
Caldwell, DM; Dalili, MN; Keeney, E; López-López, JA; Munafò, MR; Phillippo, DM; Stevenson, M; Thomas, KH; Welton, NJ2
de Chazeron, I; Jaafari, N; Peiffer, G; Perriot, J; Ruppert, AM; Underner, M1
Boezen, HM; Bos, JHJ; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B1
Babazono, A; Fujita, T; Jamal, A; Jiang, P; Li, Y1
Goldman, RD; Yan, T1
Evers-Casey, S; Leone, FT1
Choi, SKY; Chow, CK; Filion, KB; Havard, A; Pearson, SA; Tran, DT1
Hartmann-Boyce, J; Kruse, GR; Livingstone-Banks, J; Rigotti, NA1
Hussain, S; Le Foll, B; Mansoursadeghi-Gilan, T; Selby, P; Veldhuizen, S; Zawertailo, L; Zhang, H1
E, F; Guo, K; Hou, L; Li, J; Li, X; Li, Y; Shang, X; Wang, S; Yang, K1
Anthenelli, RM; Beneventi, D; Blalock, JA; Cinciripini, PM; Green, C; Karam-Hage, M; Kypriotakis, G; Lawrence, D; Minnix, J; Morris, C1
Abramson, MJ; Bonevski, B; George, J; Gobarani, RK; Ilomäki, J; Wood, S1
Perkins, KA1
Humair, JP; Papachristou, C1
Bauld, L; Beard, E; Brown, J; Kock, L; Shahab, L; Tattan-Birch, H; West, R1
Chang, CT; Choo, SJ; Harun, SN; Latif, MFA; Sanusi, NA; Tangiisuran, B1
Kang, DW; Lee, EK; Park, SK1
Hendershot, CS; Zaso, MJ1
Fulone, I; Kathuria, H; Leone, FT; Lopes, LC; Murray, RL; O'Brien, KK; Pavalagantharajah, S; Ross, S; Sachs, DPL; Zhang, Y; Zhang, YQ; Zhu, M1
Baliunas, D; Comans, T; Gartner, C; Hollingworth, SA; Pole, JD; Sullivan, C1
E, F; Guo, K; Li, M; Li, X; Li, Y; Shang, X; Wang, Y; Wu, Y; Xu, M; Yang, C; Yang, K; Zhou, L1
Daumit, GL; McGinty, EE; Murphy, KA; Stone, E; White, SA1
Dakkak, M; Gaddey, HL; Jackson, NM1
Gilbert, E; Hussain, S; Le Foll, B; Selby, P; Veldhuizen, S; Zawertailo, L; Zhang, H1
Barrett, ST; Bevins, RA; Dwoskin, LP; Huynh, YW; Thompson, BM; Tracy, ME1
Bahnisch, J; Demirkol, A; Lin, C; Lobbe, C; Murnion, B1
Laucho-Contreras, ME; Montes de Oca, M1
Kumamaru, H; Matsuyama, Y; Takeuchi, Y; Yokoyama, R1
Cinciripini, P; Green, C; Hwang, LY; Lerman, C; Pedroza, C; Rajan, SS; Suchting, R; Truong, VTT; Tyndale, RF1
Eisenberg, MJ; Huerne, K1
Fanshawe, TR; Hajizadeh, A; Hartman, L; Lindson, N; Livingstone-Banks, J; Theodoulou, A; Thomas, KH1
Agarwal, A; Das, M; Jaiswal, PL; Kashyap, P1
Hajizadeh, A; Hartmann-Boyce, J; Howes, S; Klemperer, E; Lindson, N; Livingstone-Banks, J; Theodoulou, A1
Asfar, T; Bursac, Z; Eissenberg, T; Ghaddar, T; Livingstone-Banks, J; Maziak, W; Oluwole, O; Ward, KD1
Eisenberg, MJ; Moiz, A1
Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Greiner, KA; Leavens, ELS; Mayo, MS; Nollen, NL; Salzman, G; Shanks, D; Woodward, J1
Deng, X; E, F; Guo, K; Li, X; Liang, S; Liu, W; Shang, X; Wang, Y; Wang, Z; Wu, Y; Yang, K; Zhou, L1
Cabrera-César, E; de Granda-Orive, JI; De Higes-Martínez, E; García Rueda, M; Jiménez-Ruiz, CA; Pastor-Esplá, E; Rábade-Castedo, C; Ramos-Pinedo, Á; Riesco-Miranda, JA; Signes-Costa Miñana, J1
Dennis, BB; Devereaux, PJ; Fairbairn, N; Lu, C; Mbuagbaw, L; Ofori, S; Olasupo, OO1
Davis, JM; Masclans, L; Rose, JE1
Agrawal, S; Aveyard, P; Fanshawe, TR; Freeman, SC; Hajizadeh, A; Hartmann-Boyce, J; Lindson, N; Livingstone-Banks, J; Ordóñez-Mena, JM; Sutton, AJ; Theodoulou, A; Zhu, S1

Reviews

166 review(s) available for bupropion and varenicline

ArticleYear
Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.
    Journal of medicinal chemistry, 2014, Oct-23, Volume: 57, Issue:20

    Topics: Alkaloids; Antidepressive Agents; Azetidines; Azocines; Depression; Humans; Ligands; Molecular Targeted Therapy; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Receptors, Nicotinic

2014
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Pharmacologic interventions for smoking cessation.
    Critical care nursing clinics of North America, 2006, Volume: 18, Issue:1

    Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline

2006
Varenicline: a review of its use as an aid to smoking cessation therapy.
    CNS drugs, 2006, Volume: 20, Issue:11

    Topics: Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Humans; Quinoxalines; Smoking Cessation; Varenicline

2006
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
    BMC public health, 2006, Dec-11, Volume: 6

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline

2006
Non-nicotinic therapies for smoking cessation.
    Annual review of pharmacology and toxicology, 2007, Volume: 47

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2007
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease.
    Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1

    Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Directive Counseling; Hospitalization; Humans; Neurotransmitter Uptake Inhibitors; Nicotinic Agonists; Nortriptyline; Quinoxalines; Referral and Consultation; Risk Reduction Behavior; Smoking; Smoking Cessation; Varenicline

2007
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
    Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1

    Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline

2007
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
    Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1

    Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Hospitalization; Humans; Internet; Physician's Role; Practice Patterns, Physicians'; Quinoxalines; Receptors, Nicotinic; Risk Reduction Behavior; Smoking Cessation; Tobacco Use Disorder; Varenicline

2007
[Varenicline--a new drug for smoking cessation].
    Medizinische Monatsschrift fur Pharmazeuten, 2007, Volume: 30, Issue:3

    Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Varenicline

2007
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
    Primary care, 2007, Volume: 34, Issue:1

    Topics: Age Factors; Benzazepines; Bupropion; Complementary Therapies; Dopamine Uptake Inhibitors; Dosage Forms; Humans; Nicotine; Nicotinic Agonists; Physician's Role; Primary Health Care; Quinoxalines; Referral and Consultation; Smoking Cessation; Tobacco Use Disorder; Varenicline

2007
Smoking cessation: lessons learned from clinical trial evidence.
    Current opinion in cardiology, 2007, Volume: 22, Issue:4

    Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2007
Optimizing on smoke free legislation making the most of the opportunity.
    British journal of community nursing, 2007, Volume: 12, Issue:8

    Topics: Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Nurse's Role; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Public Facilities; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; United Kingdom; Varenicline

2007
Treating tobacco dependence in women.
    Journal of women's health (2002), 2007, Volume: 16, Issue:8

    Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline; Women's Health

2007
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:17

    Topics: Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Partial Agonism; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline

2007
Treatment of tobacco dependence: integrating recent progress into practice.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2007, Nov-20, Volume: 177, Issue:11

    Topics: Behavior Therapy; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Health Behavior; Health Policy; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline

2007
Breaking the ties of nicotine dependence.
    The Nurse practitioner, 2007, Volume: 32, Issue:11

    Topics: Algorithms; Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Primary Health Care; Quinoxalines; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline

2007
An update on therapeutics for tobacco dependence.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1

    Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline

2008
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
    Psychopharmacology, 2008, Volume: 197, Issue:3

    Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline

2008
Smoking cessation and lung cancer: oncology nurses can make a difference.
    Seminars in oncology nursing, 2008, Volume: 24, Issue:1

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Information Services; Lung Neoplasms; Nicotine; Oncology Nursing; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2008
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People

2008
Smoking cessation in pregnancy: why, how, and what next...
    Clinical obstetrics and gynecology, 2008, Volume: 51, Issue:2

    Topics: Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Nicotine; Pregnancy; Pregnancy Outcome; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2008
[The ABC of smoking cessation].
    Medizinische Monatsschrift fur Pharmazeuten, 2008, Volume: 31, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Humans; Hypnosis; Motivation; Nicotiana; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2008
Which drug to be used in smoking cessation?
    Polskie Archiwum Medycyny Wewnetrznej, 2008, Volume: 118, Issue:6

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline

2008
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Jul-15, Volume: 179, Issue:2

    Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline

2008
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2008, Jul-16, Issue:3

    Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline

2008
The relevance and treatment of cue-induced cravings in tobacco dependence.
    Journal of substance abuse treatment, 2009, Volume: 36, Issue:3

    Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cues; Extinction, Psychological; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2009
Drugs for tobacco dependence.
    Treatment guidelines from the Medical Letter, 2008, Volume: 6, Issue:73

    Topics: Adrenergic alpha-Agonists; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2008
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
    Annual review of pharmacology and toxicology, 2009, Volume: 49

    Topics: Animals; Behavior, Addictive; Benzazepines; Bupropion; Ganglionic Stimulants; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Quinoxalines; Smoking; Tobacco Use Disorder; Varenicline

2009
[Modern medical support for smoking cessation].
    Der Internist, 2009, Volume: 50, Issue:1

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline

2009
[Not smoking, essential for healthy lungs].
    Pharmazie in unserer Zeit, 2008, Volume: 37, Issue:6

    Topics: Administration, Cutaneous; Benzazepines; Bupropion; Chewing Gum; Health; Humans; Lung; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tablets; Varenicline

2008
Smoking cessation in pregnancy.
    Expert opinion on drug safety, 2008, Volume: 7, Issue:6

    Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Smoking Cessation; Varenicline

2008
New findings on nicotine addiction and treatment.
    Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 2009, Volume: 55

    Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline

2009
Tobacco smoking cessation management: integrating varenicline in current practice.
    Vascular health and risk management, 2008, Volume: 4, Issue:4

    Topics: Behavior Therapy; Benzazepines; Bupropion; Drug Partial Agonism; Health Policy; Humans; Nicotinic Agonists; Public Policy; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2008
Pharmacotherapy for smoking cessation.
    Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Benzazepines; Bupropion; Humans; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Rimonabant; Smoking Cessation; Treatment Outcome; Varenicline

2008
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Przeglad lekarski, 2008, Volume: 65, Issue:10

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline

2008
A preliminary benefit-risk assessment of varenicline in smoking cessation.
    Drug safety, 2009, Volume: 32, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2009
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
    Pharmacology & therapeutics, 2009, Volume: 123, Issue:1

    Topics: Animals; Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2009
Varenicline: a first-line treatment option for smoking cessation.
    Clinical therapeutics, 2009, Volume: 31, Issue:3

    Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline

2009
Update on smoking cessation therapies.
    Advances in therapy, 2009, Volume: 26, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost of Illness; Drug Approval; Global Health; Humans; Morbidity; Nicotine; Nicotinic Agonists; Quinoxalines; Safety; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United States; Varenicline

2009
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
    International journal of environmental research and public health, 2009, Volume: 6, Issue:1

    Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2009
Pharmacogenetics of smoking cessation therapy.
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2010, Jan-05, Volume: 153B, Issue:1

    Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; Pharmacogenetics; Quinoxalines; Smoking Cessation; Varenicline

2010
Tobacco use among individuals with intellectual or developmental disabilities: a brief review.
    Intellectual and developmental disabilities, 2009, Volume: 47, Issue:3

    Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Disabled Persons; Health Policy; Humans; Nicotine; Persons with Mental Disabilities; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States; Varenicline

2009
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
    Therapeutic advances in respiratory disease, 2009, Volume: 3, Issue:4

    Topics: Animals; Antioxidants; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Maternal-Fetal Exchange; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Respiratory System; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline

2009
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009, Volume: 11, Issue:11

    Topics: Animals; Benzazepines; Bupropion; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Nicotine; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline

2009
Varenicline in the management of smoking cessation: a single technology appraisal.
    Health technology assessment (Winchester, England), 2009, Volume: 13 Suppl 2

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Nicotinic Agonists; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Varenicline

2009
Nicotine dependence and smoking cessation.
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2009, Volume: 34, Issue:11

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2009
Current approaches to pharmacotherapy for smoking cessation.
    Therapeutic advances in respiratory disease, 2010, Volume: 4, Issue:1

    Topics: Adolescent; Adult; Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline

2010
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    PharmacoEconomics, 2010, Volume: 28, Issue:3

    Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Health Care Costs; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Prevalence; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2010
Smoking cessation intervention: an evidence-based approach.
    Postgraduate medicine, 2010, Volume: 122, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Directive Counseling; Drug Therapy, Combination; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2010
Improving the effectiveness of tobacco use cessation (TUC).
    International dental journal, 2010, Volume: 60, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Chewing Gum; Counseling; Dental Offices; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Referral and Consultation; Smoking; Tobacco Use Cessation; Varenicline

2010
Smoking cessation-recent advances.
    Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4

    Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline

2010
Comparison of available treatments for tobacco addiction.
    Current psychiatry reports, 2010, Volume: 12, Issue:5

    Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2010
[Preventive relapse treatment for tobacco cessation - is it worthwhile?].
    Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:8

    Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Treatment Outcome; Varenicline

2010
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
    Journal of the American Academy of Nurse Practitioners, 2010, Volume: 22, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline

2010
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
    Current medicinal chemistry, 2011, Volume: 18, Issue:1

    Topics: Benzazepines; Bupropion; Genetic Variation; Humans; Nicotine; Protein Subunits; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline

2011
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Drugs, 2010, Dec-24, Volume: 70, Issue:18

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2010
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2010, Dec-08, Issue:12

    Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2010
Interventions for smokeless tobacco use cessation.
    The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2

    Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline

2011
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2

    Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2011
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
    Primary care, 2011, Volume: 38, Issue:1

    Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline

2011
Pharmacotherapy for smoking cessation: present and future.
    Current pharmaceutical design, 2011, Volume: 17, Issue:14

    Topics: Adolescent; Animals; Benzazepines; Bupropion; Delayed-Action Preparations; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline

2011
Clinical practice. Treating smokers in the health care setting.
    The New England journal of medicine, 2011, Sep-29, Volume: 365, Issue:13

    Topics: Benzazepines; Bupropion; Cholinergic Agents; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Humans; Middle Aged; Motivation; Nicotine; Patient Compliance; Physician-Patient Relations; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline

2011
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Paediatric drugs, 2012, Apr-01, Volume: 14, Issue:2

    Topics: Adolescent; Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Prescription Drugs; Quinoxalines; Randomized Controlled Trials as Topic; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2012
Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
    International journal of clinical practice, 2012, Volume: 66, Issue:2

    Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Humans; Markov Chains; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline

2012
[Smoking cessation in medical practice--new possibilities?].
    Revue medicale suisse, 2012, Jan-25, Volume: 8, Issue:325

    Topics: Benzazepines; Bupropion; Complementary Therapies; Drugs, Investigational; General Practitioners; Humans; Nicotine; Nicotinic Agonists; Professional Practice; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2012
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

    Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2012
Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis.
    BJOG : an international journal of obstetrics and gynaecology, 2012, Volume: 119, Issue:9

    Topics: Adult; Benzazepines; Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Epidemiologic Methods; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult

2012
Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.
    Annals of medicine, 2012, Volume: 44, Issue:6

    Topics: Benzazepines; Bupropion; Databases, Bibliographic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2012
Health impact of smoking and smoking cessation strategies: current evidence.
    British journal of community nursing, 2012, Volume: 17, Issue:8

    Topics: Benzazepines; Bupropion; Cause of Death; Counseling; Evidence-Based Medicine; Humans; Nicotinic Agonists; Nurse's Role; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Tobacco Use Cessation Devices; United Kingdom; Varenicline

2012
The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
    Journal of pharmacy practice, 2012, Volume: 25, Issue:6

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Education, Pharmacy, Continuing; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pharmacists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline

2012
Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
    The Cochrane database of systematic reviews, 2012, Dec-12, Volume: 12

    Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2012
[Smoking in COPD].
    Archivos de bronconeumologia, 2011, Volume: 47 Suppl 8

    Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline

2011
[Drugs used to treat nicotine addiction].
    Przeglad lekarski, 2012, Volume: 69, Issue:10

    Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult

2012
Interventions for smoking cessation and reduction in individuals with schizophrenia.
    The Cochrane database of systematic reviews, 2013, Feb-28, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline

2013
Smoking cessation and COPD.
    European respiratory review : an official journal of the European Respiratory Society, 2013, Mar-01, Volume: 22, Issue:127

    Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline

2013
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
    British journal of clinical pharmacology, 2014, Volume: 77, Issue:2

    Topics: Adolescent; Benzazepines; Bupropion; Counseling; Drug Design; Female; Humans; Molecular Sequence Data; Pregnancy; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2014
[Current approaches to smoking cessation].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:17

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cooperative Behavior; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Germany; Health Priorities; Health Surveys; Humans; Interdisciplinary Communication; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult

2013
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    The Cochrane database of systematic reviews, 2013, May-31, Issue:5

    Topics: Adult; Alkaloids; Antidepressive Agents, Second-Generation; Azocines; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2013
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2013, Volume: 79, Issue:1

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2013
A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success.
    Addiction (Abingdon, England), 2014, Volume: 109, Issue:1

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Medication Adherence; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2014
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:14

    Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2013
Cochrane review summary: Pharmacological interventions for promoting smoking cessation during pregnancy.
    Primary health care research & development, 2013, Volume: 14, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Birth Weight; Bupropion; Female; Humans; Infant, Newborn; Medication Adherence; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2013
Managing tobacco use: the neglected cardiovascular disease risk factor.
    European heart journal, 2013, Volume: 34, Issue:42

    Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Counseling; Female; Health Promotion; Humans; Male; Nicotinic Agonists; Physician's Role; Quinoxalines; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2013
Safety of varenicline in patients with cardiovascular disease.
    Journal of pharmacy practice, 2014, Volume: 27, Issue:1

    Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2014
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.
    Psychopharmacology, 2014, Volume: 231, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Cross-Over Studies; Drug Evaluation, Preclinical; Feasibility Studies; Humans; Quinoxalines; Research Design; Smoking Cessation; Validation Studies as Topic; Varenicline

2014
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
    Circulation, 2014, Jan-07, Volume: 129, Issue:1

    Topics: Adult; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline

2014
Pharmacological intervention of nicotine dependence.
    BioMed research international, 2013, Volume: 2013

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2013
Smoking cessation.
    Clinics in chest medicine, 2014, Volume: 35, Issue:1

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2014
Emerging drugs for the treatment of tobacco dependence: 2014 update.
    Expert opinion on emerging drugs, 2014, Volume: 19, Issue:2

    Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2014
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
    Addiction (Abingdon, England), 2014, Volume: 109, Issue:9

    Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; School Health Services; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline

2014
Is it safe to use smoking cessation therapeutics during pregnancy?
    Expert opinion on drug safety, 2014, Volume: 13, Issue:12

    Topics: Animals; Benzazepines; Bupropion; Female; Humans; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2014
Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
    Current cardiology reports, 2015, Volume: 17, Issue:1

    Topics: Benzazepines; Bupropion; Chest Pain; Dose-Response Relationship, Drug; Humans; Hypertension; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Randomized Controlled Trials as Topic; Seizures; Smoking Cessation; Smoking Prevention; Tachycardia; Varenicline

2015
Interventions to increase adherence to medications for tobacco dependence.
    The Cochrane database of systematic reviews, 2015, Feb-23, Issue:2

    Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Varenicline

2015
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.
    Schizophrenia bulletin, 2016, Volume: 42, Issue:1

    Topics: Behavior Therapy; Bipolar Disorder; Bupropion; Cardiovascular Diseases; Diabetes Mellitus; Dopamine Uptake Inhibitors; Health Behavior; HIV Infections; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Metformin; Motor Activity; Nicotinic Agonists; Obesity; Overweight; Risk Reduction Behavior; Schizophrenia; Smoking; Smoking Cessation; Varenicline

2016
Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
    International journal of environmental research and public health, 2015, Aug-25, Volume: 12, Issue:9

    Topics: Adult; Aged; Benzazepines; Bupropion; Female; Humans; Intention; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline

2015
The Past, Present, and Future of Nicotine Addiction Therapy.
    Annual review of medicine, 2016, Volume: 67

    Topics: Alkaloids; Azocines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Policy; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Social Media; Text Messaging; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2016
Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force.
    Annals of internal medicine, 2015, Oct-20, Volume: 163, Issue:8

    Topics: Adult; Behavior Therapy; Bupropion; Counseling; Electronic Nicotine Delivery Systems; Female; Humans; Nicotinic Agonists; Pregnancy; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline

2015
Smoking cessation and reduction in people with chronic mental illness.
    BMJ (Clinical research ed.), 2015, Sep-21, Volume: 351

    Topics: Anxiety Disorders; Bipolar Disorder; Bupropion; Electronic Nicotine Delivery Systems; Humans; Mental Disorders; Mentally Ill Persons; Nicotinic Agonists; Prevalence; Reinforcement, Psychology; Schizophrenia; Smoking; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Cessation Devices; United Kingdom; United States; Varenicline

2015
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
    The Cochrane database of systematic reviews, 2015, Oct-12, Issue:10

    Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
Effective Cessation Strategies for Smokers with Schizophrenia.
    International review of neurobiology, 2015, Volume: 124

    Topics: Antipsychotic Agents; Behavior Therapy; Bupropion; Humans; Schizophrenia; Smoking Cessation; Tobacco Use Disorder; Varenicline

2015
Interventions for smokeless tobacco use cessation.
    The Cochrane database of systematic reviews, 2015, Oct-26, Issue:10

    Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline

2015
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Addiction (Abingdon, England), 2016, Volume: 111, Issue:4

    Topics: Bupropion; Humans; Mental Disorders; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline

2016
Smoking Cessation Strategies in Pregnancy.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015, Volume: 37, Issue:9

    Topics: Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotinic Agonists; Pregnancy; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
Pharmacological interventions for promoting smoking cessation during pregnancy.
    The Cochrane database of systematic reviews, 2015, Dec-22, Issue:12

    Topics: Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
The safety of treatments for tobacco use disorder.
    Expert opinion on drug safety, 2016, Volume: 15, Issue:3

    Topics: Bupropion; Delayed-Action Preparations; Humans; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2016
Cardiac adverse effects of nicotine replacement therapy.
    Prescrire international, 2015, Volume: 24, Issue:166

    Topics: Bupropion; Cardiovascular Diseases; Humans; Tobacco Use Cessation Devices; Varenicline

2015
Combination bupropion SR and varenicline for smoking cessation: a systematic review.
    The American journal of drug and alcohol abuse, 2016, Volume: 42, Issue:2

    Topics: Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Smoking Cessation; Varenicline

2016
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2016, May-09, Issue:5

    Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline

2016
Pharmacotherapy for Substance Use Disorders.
    The Medical clinics of North America, 2016, Volume: 100, Issue:4

    Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2016
Evaluating the effectiveness of smoking cessation in the management of COPD.
    British journal of nursing (Mark Allen Publishing), 2016, Jul-28, Volume: 25, Issue:14

    Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Humans; Nicotinic Agonists; Nurse's Role; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Varenicline

2016
Smoking cessation for people with chronic obstructive pulmonary disease.
    The Cochrane database of systematic reviews, 2016, Aug-20, Issue:8

    Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline

2016
Managing smoking cessation.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Dec-06, Volume: 188, Issue:17-18

    Topics: Aftercare; Behavior Therapy; Bupropion; Canada; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2016
Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline.
    Drug and alcohol dependence, 2016, Dec-01, Volume: 169

    Topics: Adult; Bupropion; Clinical Trials as Topic; Female; Humans; Laboratories; Middle Aged; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Varenicline

2016
Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Circulation. Cardiovascular quality and outcomes, 2017, Volume: 10, Issue:1

    Topics: Bupropion; Cardiovascular Diseases; Counseling; Humans; Network Meta-Analysis; Nicotinic Agonists; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Varenicline

2017
Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.
    Journal of midwifery & women's health, 2017, Volume: 62, Issue:3

    Topics: Bupropion; Female; Fetus; Humans; Lactation; Nicotiana; Nicotine; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2017
Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
    BMC psychiatry, 2017, 07-14, Volume: 17, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Mental Disorders; Nicotinic Agonists; Smoking; Smoking Cessation; Varenicline

2017
Lung Cancer: Smoking Cessation.
    FP essentials, 2018, Volume: 464

    Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Mass Screening; Nicotinic Agonists; Psychotherapy, Group; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2018
Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
    Addiction (Abingdon, England), 2018, Volume: 113, Issue:5

    Topics: Bupropion; Humans; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2018
Smoking Cessation in Patients With Acute Coronary Syndrome.
    The American journal of cardiology, 2018, 05-01, Volume: 121, Issue:9

    Topics: Acute Coronary Syndrome; Behavior Therapy; Bupropion; Cardiac Rehabilitation; Counseling; Electronic Nicotine Delivery Systems; Humans; Motivation; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2018
Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019, 07-17, Volume: 21, Issue:8

    Topics: Bupropion; Case-Control Studies; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline

2019
Discovery and development of varenicline for smoking cessation.
    Expert opinion on drug discovery, 2018, Volume: 13, Issue:7

    Topics: Animals; Bupropion; Drug Development; Drug Discovery; Humans; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline

2018
[Interventions for smoking cessation in 2018].
    Revue de pneumologie clinique, 2018, Volume: 74, Issue:3

    Topics: Bupropion; History, 21st Century; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2018
Treatment of tobacco dependence: current state of the art.
    Current opinion in pulmonary medicine, 2018, Volume: 24, Issue:4

    Topics: Bupropion; Directive Counseling; Early Detection of Cancer; Humans; Lung Neoplasms; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2018
[Smoking cessation: Pharmacological strategies different from standard treatments].
    Revue de pneumologie clinique, 2018, Volume: 74, Issue:4

    Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Standard of Care; Tobacco Use Cessation Devices; Varenicline

2018
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.
    Expert review of respiratory medicine, 2018, Volume: 12, Issue:9

    Topics: Bupropion; Combined Modality Therapy; Humans; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline

2018
Pharmaceutical strategies for smoking cessation during pregnancy.
    Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:18

    Topics: Bupropion; Female; Humans; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2018
Study Characteristics Influence the Efficacy of Substance Abuse Treatments: A Meta-analysis of Medications for Smoking Cessation.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2020, 03-16, Volume: 22, Issue:3

    Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Smoking Cessation; Smoking Cessation Agents; Substance-Related Disorders; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2020
The efficacy of smoking cessation interventions in low- and middle-income countries: a systematic review and meta-analysis.
    Addiction (Abingdon, England), 2019, Volume: 114, Issue:4

    Topics: Adult; Behavior Therapy; Bupropion; Cigarette Smoking; Clonidine; Counseling; Developing Countries; Humans; Mobile Applications; Naltrexone; Nortriptyline; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2019
Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.
    Journal of the American College of Cardiology, 2018, 12-11, Volume: 72, Issue:23 Pt B

    Topics: Bupropion; Cigarette Smoking; Health Promotion; Humans; Smoking Cessation; Tobacco Use; Tobacco Use Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2018
Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
    Addiction (Abingdon, England), 2019, Volume: 114, Issue:5

    Topics: Biobehavioral Sciences; Bupropion; Follow-Up Studies; Humans; Randomized Controlled Trials as Topic; Recurrence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2019
Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019, 08-19, Volume: 21, Issue:9

    Topics: Bupropion; Clinical Trials as Topic; Female; Genetic Markers; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Prospective Studies; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2019
Relapse prevention interventions for smoking cessation.
    The Cochrane database of systematic reviews, 2019, 02-13, Volume: 2

    Topics: Behavior Therapy; Bupropion; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Cessation Agents; Smoking Prevention; Varenicline

2019
SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS.
    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2019, Volume: 71, Issue:1

    Topics: Bupropion; Cognitive Behavioral Therapy; Humans; Mexico; Motivational Interviewing; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2019
[Smoking, alcohol and diabetes (Update 2019)].
    Wiener klinische Wochenschrift, 2019, Volume: 131, Issue:Suppl 1

    Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2019
[Stopping and reducing smoking in patients with schizophrenia].
    L'Encephale, 2019, Volume: 45, Issue:4

    Topics: Bupropion; Cognitive Behavioral Therapy; Electronic Nicotine Delivery Systems; Humans; Nicotine; Reinforcement, Psychology; Schizophrenia; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline

2019
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
    The Cochrane database of systematic reviews, 2019, 06-05, Volume: 6

    Topics: Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2019
[Behavioral and cognitive therapies in smoking cessation: What tools for the pulmonologist?]
    Revue des maladies respiratoires, 2019, Volume: 36, Issue:5

    Topics: Behavior Therapy; Bupropion; Cognitive Behavioral Therapy; Humans; Motivation; Pulmonary Medicine; Pulmonologists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2019
[Smoking cessation: How can we involve patients better in treatment choice?]
    Revue des maladies respiratoires, 2019, Volume: 36, Issue:5

    Topics: Bupropion; Choice Behavior; Counseling; Decision Making, Shared; Humans; Nicotine; Patient Participation; Patient Selection; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2019
Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade.
    Handbook of experimental pharmacology, 2020, Volume: 258

    Topics: Bupropion; Humans; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2020
Drugs for smoking cessation.
    The Medical letter on drugs and therapeutics, 2019, Jul-15, Volume: 61, Issue:1576

    Topics: Bupropion; Humans; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2019
Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
    Comprehensive psychiatry, 2019, Volume: 95

    Topics: Adult; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline

2019
Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
    Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:5

    Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2020
Antidepressants for smoking cessation.
    The Cochrane database of systematic reviews, 2020, 04-22, Volume: 4

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Bupropion; Humans; Nortriptyline; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2020
Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 78

    Topics: Bupropion; Female; Humans; Ischemic Attack, Transient; Observational Studies as Topic; Randomized Controlled Trials as Topic; Seizures; Smoking; Smoking Cessation; Stroke; Tobacco Use Cessation Devices; Varenicline

2020
Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2020, Volume: 27, Issue:5

    Topics: Alkaloids; Azocines; Bupropion; Clinical Decision-Making; Electronic Nicotine Delivery Systems; Humans; Quinolizines; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline

2020
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
    Neuropharmacology, 2020, 11-01, Volume: 178

    Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2020
Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
    The lancet. Psychiatry, 2020, Volume: 7, Issue:9

    Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Network Meta-Analysis; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Varenicline

2020
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
    Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:7

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2021
Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2021, Volume: 24, Issue:6

    Topics: Bupropion; Cost-Benefit Analysis; Depression; Drug Costs; Electronic Nicotine Delivery Systems; Humans; Markov Chains; Models, Economic; Monte Carlo Method; Network Meta-Analysis; Nicotinic Agonists; Quality-Adjusted Life Years; Recurrence; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline

2021
[Combinations of pharmacological treatments in smoking cessation. A systematic review].
    Revue des maladies respiratoires, 2021, Volume: 38, Issue:7

    Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Varenicline

2021
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials.
    Addiction (Abingdon, England), 2022, Volume: 117, Issue:4

    Topics: Adult; Bayes Theorem; Bupropion; Electronic Nicotine Delivery Systems; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2022
Tobacco Use Disorder.
    The Medical clinics of North America, 2022, Volume: 106, Issue:1

    Topics: Behavior, Addictive; Bupropion; Combined Modality Therapy; Counseling; Drug Therapy; Electronic Nicotine Delivery Systems; Humans; Morbidity; Neurobiology; Nicotine; Nicotinic Agonists; Phenotype; Prevalence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline

2022
Treatment of Tobacco Smoking: A Review.
    JAMA, 2022, Feb-08, Volume: 327, Issue:6

    Topics: Behavior Therapy; Bupropion; Drug Therapy, Combination; Electronic Nicotine Delivery Systems; Humans; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline

2022
The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials.
    Addictive behaviors, 2022, Volume: 131

    Topics: Bupropion; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2022
Effects of varenicline and bupropion on laboratory smoking outcomes: Meta-analysis of randomized, placebo-controlled human laboratory studies.
    Addiction biology, 2022, Volume: 27, Issue:5

    Topics: Bupropion; Humans; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2022
Varenicline for Tobacco-Dependent Adults Who Are Not Ready to Discontinue Use: A Systematic Review and Meta-Analysis.
    Annals of the American Thoracic Society, 2022, Volume: 19, Issue:12

    Topics: Adult; Bupropion; Humans; Nicotiana; Nicotinic Agonists; Smoking Cessation; Tobacco Use; Varenicline

2022
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis.
    Drug and alcohol dependence, 2022, Dec-01, Volume: 241

    Topics: Benzazepines; Bupropion; Humans; Network Meta-Analysis; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2022
Vaping-Cessation Interventions in Former Smokers.
    The Canadian journal of cardiology, 2023, Volume: 39, Issue:9

    Topics: Adult; Bupropion; Humans; Nicotinic Agonists; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Vaping; Varenicline

2023
Nicotine receptor partial agonists for smoking cessation.
    The Cochrane database of systematic reviews, 2023, 05-05, Volume: 5

    Topics: Alkaloids; Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2023
Antidepressants for smoking cessation.
    The Cochrane database of systematic reviews, 2023, 05-24, Volume: 5

    Topics: Adolescent; Adult; Antidepressive Agents; Bupropion; Child; Humans; Nicotinic Agonists; Nortriptyline; Smoking Cessation; Varenicline; Young Adult

2023
Interventions for waterpipe smoking cessation.
    The Cochrane database of systematic reviews, 2023, 06-07, Volume: 6

    Topics: Adolescent; Bupropion; Female; Humans; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Water Pipe Smoking

2023
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
    Addiction biology, 2023, Volume: 28, Issue:8

    Topics: Alcoholism; Antidepressive Agents; Bupropion; Humans; Network Meta-Analysis; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2023
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023.
    Archivos de bronconeumologia, 2023, Volume: 59, Issue:10

    Topics: Adolescent; Alcoholism; Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pulmonary Medicine; Smoking Cessation; Thoracic Surgery; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2023
Cytisine for smoking cessation: A systematic review and meta-analysis.
    Drug and alcohol dependence, 2023, 10-01, Volume: 251

    Topics: Adult; Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Varenicline

2023
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.
    The Cochrane database of systematic reviews, 2023, 09-12, Volume: 9

    Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Female; Humans; Network Meta-Analysis; Nicotine; Nortriptyline; Pregnancy; Smoking Cessation; Varenicline

2023

Trials

49 trial(s) available for bupropion and varenicline

ArticleYear
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    JAMA, 2006, Jul-05, Volume: 296, Issue:1

    Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline

2006
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    JAMA, 2006, Jul-05, Volume: 296, Issue:1

    Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline

2006
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
    Journal of occupational and environmental medicine, 2007, Volume: 49, Issue:4

    Topics: Absenteeism; Benzazepines; Bupropion; Cost Savings; Cost-Benefit Analysis; Decision Trees; Employer Health Costs; Health Benefit Plans, Employee; Humans; Maintenance; Nicotinic Agonists; Program Evaluation; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Time Factors; Varenicline

2007
Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2009, Volume: 11, Issue:3

    Topics: Adult; Aged; Benzazepines; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult

2009
Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2010, Volume: 12, Issue:6

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Humans; Male; Medication Adherence; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult

2010
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
    Addiction (Abingdon, England), 2010, Volume: 105, Issue:11

    Topics: Adolescent; Adult; Aged; Benzazepines; Breath Tests; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotinic Agonists; Placebos; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline; Young Adult

2010
Changes in health-related quality of life with smoking cessation treatment.
    European journal of public health, 2012, Volume: 22, Issue:2

    Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Health Status; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quality of Life; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome; Varenicline

2012
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Male; Midwestern United States; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult

2011
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
    Trials, 2011, May-18, Volume: 12

    Topics: Benzazepines; Bupropion; Counseling; Cultural Characteristics; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Indians, North American; Kansas; Nicotinic Agonists; Oklahoma; Patient Education as Topic; Quinoxalines; Research Design; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline

2011
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2012, Volume: 14, Issue:2

    Topics: Adolescent; Benzazepines; Bupropion; Double-Blind Method; Female; Humans; Male; Nausea; Pilot Projects; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult

2012
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
    Experimental and clinical psychopharmacology, 2012, Volume: 20, Issue:1

    Topics: Adult; Benzazepines; Bupropion; Cognition; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult

2012
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:3

    Topics: Adult; Aged; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacogenetics; Quinoxalines; Research Design; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2012
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
    Molecular psychiatry, 2014, Volume: 19, Issue:1

    Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult

2014
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
    Pharmacogenetics and genomics, 2013, Volume: 23, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Varenicline

2013
Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.
    Schizophrenia research, 2013, Volume: 146, Issue:1-3

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzazepines; Bupropion; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking; Varenicline

2013
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
    JAMA psychiatry, 2013, Volume: 70, Issue:5

    Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult

2013
Adapting smoking cessation treatment according to initial response to precessation nicotine patch.
    The American journal of psychiatry, 2013, Volume: 170, Issue:8

    Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Synergism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Premedication; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline

2013
A multicentre randomized trial of combined individual and telephone counselling for smoking cessation.
    Preventive medicine, 2013, Volume: 57, Issue:3

    Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Smoking Cessation; Smoking Prevention; Spain; Telephone; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2013
Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
    JAMA, 2014, Jan-08, Volume: 311, Issue:2

    Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2014
A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).
    BMC public health, 2014, May-07, Volume: 14

    Topics: Benzazepines; Bupropion; Canada; Female; Health Services Accessibility; Humans; Insurance, Health; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline

2014
Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    The American journal of psychiatry, 2014, Nov-01, Volume: 171, Issue:11

    Topics: Adult; Aged; Benzazepines; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline

2014
Depressive symptoms among patients receiving varenicline and bupropion for smoking cessation.
    Journal of substance abuse treatment, 2015, Volume: 52

    Topics: Adult; Bupropion; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:9

    Topics: Bupropion; Combined Modality Therapy; Counseling; Cytochrome P-450 CYP2B6; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2015
An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial.
    Journal of acquired immune deficiency syndromes (1999), 2015, Jul-01, Volume: 69, Issue:3

    Topics: Adult; Algorithms; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; HIV Infections; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial.
    Implementation science : IS, 2015, Oct-01, Volume: 10

    Topics: Adult; Bupropion; Female; Humans; Internet; Male; Middle Aged; Motivation; Office Visits; Ontario; Postal Service; Power, Psychological; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
    Lancet (London, England), 2016, Jun-18, Volume: 387, Issue:10037

    Topics: Adolescent; Adult; Aged; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult

2016
    Praxis, 2016, Volume: 105, Issue:24

    Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupropion; Cohort Studies; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Smoking Cessation; Varenicline; Young Adult

2016
Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.
    Psychopharmacology, 2017, Volume: 234, Issue:11

    Topics: Adult; Antidepressive Agents, Second-Generation; Bayes Theorem; Bupropion; Follow-Up Studies; Humans; Middle Aged; Nicotinic Agonists; Reward; Smoking Cessation; Tobacco Smoking; Treatment Outcome; Varenicline

2017
Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2017, Aug-01, Volume: 19, Issue:8

    Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Male; Nicotinic Agonists; Smokers; Smoking; Smoking Cessation; Varenicline

2017
Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019, 01-04, Volume: 21, Issue:2

    Topics: Adult; Brain; Bupropion; Cigarette Smoking; Double-Blind Method; Emotions; Female; Humans; Male; Middle Aged; Photic Stimulation; Smokers; Smoking Cessation; Smoking Cessation Agents; Treatment Outcome; Varenicline

2019
Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study.
    International journal of psychophysiology : official journal of the International Organization of Psychophysiology, 2018, Volume: 123

    Topics: Adult; Blinking; Bupropion; Delayed-Action Preparations; Emotions; Facial Muscles; Female; Humans; Male; Middle Aged; Reflex, Startle; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline

2018
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
    Addiction (Abingdon, England), 2018, Volume: 113, Issue:8

    Topics: Adult; Age Factors; Anxiety Disorders; Bupropion; Double-Blind Method; Ethnicity; Female; Humans; International Cooperation; Male; Middle Aged; Mood Disorders; Prognosis; Psychotic Disorders; Psychotropic Drugs; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Treatment Outcome; United States; Varenicline

2018
Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    JAMA internal medicine, 2018, 05-01, Volume: 178, Issue:5

    Topics: Bupropion; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Risk Factors; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2018
Mediators of the effect of nicotine pre-treatment on quitting smoking.
    Addiction (Abingdon, England), 2018, Volume: 113, Issue:12

    Topics: Adult; Behavior Therapy; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Premedication; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2018
Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
    Journal of general internal medicine, 2019, Volume: 34, Issue:6

    Topics: Adult; Bupropion; Cohort Studies; Double-Blind Method; Female; Humans; Internationality; Male; Mental Disorders; Middle Aged; Predictive Value of Tests; Prospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline

2019
Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2020, 02-06, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Chromosomes, Human, Pair 15; Female; Gastrointestinal Diseases; Genetic Variation; Humans; Male; Middle Aged; Multigene Family; Nerve Tissue Proteins; Predictive Value of Tests; Receptors, Nicotinic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use; Varenicline; Young Adult

2020
Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.
    Journal of affective disorders, 2019, 09-01, Volume: 256

    Topics: Bipolar Disorder; Bupropion; Counseling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Random Allocation; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2019
Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial.
    JAMA, 2020, 10-13, Volume: 324, Issue:14

    Topics: Aged; Bupropion; Cotinine; Counseling; Decision Support Techniques; Female; Humans; Male; Middle Aged; Motivational Interviewing; Neoplasms; Patient Satisfaction; Patient Selection; Saliva; Smoking; Smoking Cessation; Smoking Cessation Agents; Telephone; Temperance; Tobacco Use Cessation Devices; Varenicline

2020
Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES.
    Psychiatric services (Washington, D.C.), 2021, 01-01, Volume: 72, Issue:1

    Topics: Bupropion; Humans; Nicotinic Agonists; Schizophrenia; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2021
Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
    JAMA network open, 2021, 01-04, Volume: 4, Issue:1

    Topics: Black People; Bupropion; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Race Factors; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline; White People

2021
Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events, Treatment Adherence, and Smoking Cessation.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021, 08-29, Volume: 23, Issue:10

    Topics: Bupropion; Humans; Male; Multimorbidity; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Adherence and Compliance; Varenicline

2021
Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors.
    Addiction (Abingdon, England), 2021, Volume: 116, Issue:10

    Topics: Bayes Theorem; Benzazepines; Bupropion; Double-Blind Method; Humans; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation Devices; Varenicline

2021
Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
    Mayo Clinic proceedings, 2021, Volume: 96, Issue:7

    Topics: Adult; Bupropion; Drug Tapering; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2021
Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: A pragmatic randomized controlled trial (MATCH study).
    Drug and alcohol dependence, 2022, 03-01, Volume: 232

    Topics: Benzazepines; Bupropion; Humans; Internet; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline

2022
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
    Depression and anxiety, 2022, Volume: 39, Issue:5

    Topics: Bupropion; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Polyesters; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2022
E-cigarettes to Augment Stop Smoking In-person Support and Treatment With Varenicline (E-ASSIST): A Pragmatic Randomized Controlled Trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 02-09, Volume: 25, Issue:3

    Topics: Adult; Bupropion; COVID-19; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Smoking; Varenicline

2023
Effectiveness of Bupropion and Varenicline for Smokers With Baseline Depressive Symptoms.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 04-06, Volume: 25, Issue:5

    Topics: Bupropion; Depression; Humans; Nicotinic Agonists; Smokers; Varenicline

2023
Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial.
    JAMA network open, 2023, 06-01, Volume: 6, Issue:6

    Topics: Adult; Bupropion; Ethnicity; Female; Humans; Male; Middle Aged; Minority Groups; Nicotine; Smoking; Smoking Cessation; Varenicline

2023
Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
    JAMA network open, 2023, 09-05, Volume: 6, Issue:9

    Topics: Bupropion; COVID-19; Female; Humans; Male; Middle Aged; Nicotine; Pandemics; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2023

Other Studies

195 other study(ies) available for bupropion and varenicline

ArticleYear
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
[Medication for ending tobacco dependency. Current state].
    Atencion primaria, 2005, Jun-30, Volume: 36, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline

2005
Varenicline for smoking cessation: definite promise, but no panacea.
    JAMA, 2006, Jul-05, Volume: 296, Issue:1

    Topics: Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline

2006
[The path from cigarettes--with support it works better].
    Medizinische Monatsschrift fur Pharmazeuten, 2007, Volume: 30, Issue:3

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline

2007
[Tobacco use prevention and cessation in the dental practice].
    Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia, 2007, Volume: 117, Issue:3

    Topics: Behavior Therapy; Benzazepines; Bupropion; Dentist-Patient Relations; Health Plan Implementation; Humans; Interview, Psychological; Mouth Neoplasms; Nicotinic Agonists; Obesity; Periodontitis; Professional Role; Quinoxalines; Self Efficacy; Surveys and Questionnaires; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline; Weight Gain

2007
[Drug of the month. Varenicline (Champix)].
    Revue medicale de Liege, 2007, Volume: 62, Issue:2

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline

2007
[Giving up smoking is crucial for COPD patients].
    MMW Fortschritte der Medizin, 2007, Feb-22, Volume: 149, Issue:8

    Topics: Benzazepines; Bupropion; Family Practice; Humans; Patient Care Team; Patient Education as Topic; Physician-Patient Relations; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline

2007
Smoking cessation: tactics that make a big difference.
    The Journal of family practice, 2007, Volume: 56, Issue:10

    Topics: Adult; Benzazepines; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; Nortriptyline; Patient Education as Topic; Quinoxalines; Smoking Cessation; Social Support; Varenicline

2007
A new medication for the worst addiction.
    Current psychiatry reports, 2007, Volume: 9, Issue:5

    Topics: Benzazepines; Bupropion; Drug Administration Schedule; Follow-Up Studies; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2007
A second varenicline trial.
    Current psychiatry reports, 2007, Volume: 9, Issue:5

    Topics: Benzazepines; Bupropion; Delayed-Action Preparations; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2007
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
    Current medical research and opinion, 2008, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Theoretical; Netherlands; Nicotine; Nortriptyline; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2008
The truth about smoking cessation.
    The Johns Hopkins medical letter health after 50, 2007, Volume: 19, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline

2007
Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Respiratory medicine, 2008, Volume: 102, Issue:5

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cost of Illness; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Econometric; Morbidity; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Sweden; Value of Life; Varenicline

2008
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
    The pharmacogenomics journal, 2008, Volume: 8, Issue:6

    Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Genotype; Humans; Pharmacogenetics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline

2008
Drug addiction: a critical problem calling for novel solutions.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Benzazepines; Buprenorphine; Bupropion; Chronic Disease; Financing, Government; Genetic Testing; Harm Reduction; Humans; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Prevalence; Privacy; Quinoxalines; Receptors, Nicotinic; Recurrence; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance-Related Disorders; Varenicline

2008
Stat bite: Medicaid coverage of tobacco-dependence treatments.
    Journal of the National Cancer Institute, 2008, Apr-02, Volume: 100, Issue:7

    Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Oral; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Insurance Coverage; Male; Medicaid; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Tobacco Use Disorder; United States; Varenicline

2008
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
    PharmacoEconomics, 2008, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Costs and Cost Analysis; Drug Costs; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline

2008
The place of varenicline in smoking cessation treatment.
    Thorax, 2008, Volume: 63, Issue:8

    Topics: Benzazepines; Bupropion; Cholinergic Agents; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Drug Costs; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2008
Smoking cessation: the psychiatrist's role.
    Journal of psychiatry & neuroscience : JPN, 2008, Volume: 33, Issue:5

    Topics: Antimanic Agents; Benzazepines; Bipolar Disorder; Bupropion; Humans; Lithium Carbonate; Psychiatry; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline

2008
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.
    Tobacco control, 2009, Volume: 18, Issue:1

    Topics: Algorithms; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Consensus; Decision Support Techniques; Delphi Technique; Humans; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Varenicline

2009
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
    Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 2009, Volume: 55

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area

2009
Smoking cessation: new ways to quit.
    Harvard men's health watch, 2008, Volume: 13, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Behavior, Addictive; Benzazepines; Bupropion; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2008
A 51-year-old woman with bipolar disorder who wants to quit smoking.
    JAMA, 2009, Feb-04, Volume: 301, Issue:5

    Topics: Benzazepines; Bipolar Disorder; Bupropion; Counseling; Female; Humans; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline

2009
[Specific program for smoking cessation: thus your patients become nonsmokers].
    MMW Fortschritte der Medizin, 2008, Nov-13, Volume: 150, Issue:46

    Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2008
Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
    BMC public health, 2009, Jan-21, Volume: 9

    Topics: Administration, Cutaneous; Adult; Benzazepines; Bupropion; Cohort Studies; Community Health Services; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Participation; Probability; Program Evaluation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United Kingdom; Varenicline; Young Adult

2009
[Varenicline - pharmacological therapy of tobacco dependence].
    Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:1-2

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Clinical Trials as Topic; Contraindications; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Pregnancy; Prospective Studies; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline

2009
A reader responds to "Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months".
    Medscape journal of medicine, 2008, Volume: 10, Issue:12

    Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline

2008
Two recent updates for psychiatric conditions.
    Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atomoxetine Hydrochloride; Benzazepines; Bupropion; Chemical and Drug Induced Liver Injury; Congresses as Topic; Drug Labeling; Humans; Middle Aged; Product Surveillance, Postmarketing; Propylamines; Quinoxalines; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline

2009
Treatment of comorbid tobacco use in people with serious mental illness.
    Journal of psychiatry & neuroscience : JPN, 2009, Volume: 34, Issue:3

    Topics: Adult; Benzazepines; Bupropion; Comorbidity; Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Schizophrenia, Paranoid; Smoking; Smoking Cessation; Varenicline

2009
[Current and future medical drugs for smoking cessation].
    Laryngo- rhino- otologie, 2009, Volume: 88, Issue:6

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline

2009
Cost-effectiveness of varenicline for smoking cessation.
    Expert review of pharmacoeconomics & outcomes research, 2009, Volume: 9, Issue:3

    Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2009
Safety of smoking cessation drugs.
    The Medical letter on drugs and therapeutics, 2009, Aug-24, Volume: 51, Issue:1319

    Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2009
Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy.
    Acta bio-medica : Atenei Parmensis, 2009, Volume: 80, Issue:1

    Topics: Adult; Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; Directive Counseling; Female; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Retrospective Studies; Smoking Cessation; Treatment Outcome; Varenicline

2009
Varenicline gets stronger warnings about psychiatric problems, vehicle crashes.
    JAMA, 2009, Aug-26, Volume: 302, Issue:8

    Topics: Accidents, Traffic; Benzazepines; Bupropion; Drug Labeling; Humans; Neurotransmitter Agents; Quinoxalines; Receptors, Nicotinic; Risk; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline

2009
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Clinical drug investigation, 2009, Volume: 29, Issue:10

    Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Belgium; Benzazepines; Bupropion; Computer Simulation; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult

2009
Smoking cessation: how to advise the patient.
    Heart (British Cardiac Society), 2009, Volume: 95, Issue:19

    Topics: Ambulatory Care; Behavior Therapy; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline

2009
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
    BMJ (Clinical research ed.), 2009, Oct-01, Volume: 339

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Family Practice; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Suicide; Varenicline; Young Adult

2009
Smoking cessation agents and suicide.
    BMJ (Clinical research ed.), 2009, Nov-05, Volume: 339

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Quinoxalines; Self-Injurious Behavior; Smoking Cessation; Suicide; Varenicline; Young Adult

2009
[Drug treatment of tobacco dependence].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:47

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2009
Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Current medical research and opinion, 2010, Volume: 26, Issue:3

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Costs and Cost Analysis; Databases, Factual; Dopamine Uptake Inhibitors; Female; Finland; Humans; Male; Markov Chains; Middle Aged; Models, Theoretical; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2010
Integrating smoking cessation into HIV care.
    AIDS patient care and STDs, 2010, Volume: 24, Issue:3

    Topics: Anti-HIV Agents; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Government Programs; HIV Infections; Humans; Nicotinic Agonists; Oregon; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline

2010
Current treatment options in smoking cessation.
    Hospital practice (1995), 2010, Volume: 38, Issue:1

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline

2010
[The management of patients with nicotine dependence - the role of the general practitioners].
    Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:8

    Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Disease Management; Dopamine Uptake Inhibitors; Family Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Switzerland; Tobacco Use Disorder; Varenicline

2010
[Medical therapy for smoking cessation].
    Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:8

    Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Antidepressive Agents; Benzazepines; Bupropion; Chewing Gum; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2010
Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
    Drug and alcohol dependence, 2011, Mar-01, Volume: 114, Issue:1

    Topics: Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult

2011
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Bupropion; Canada; Cohort Studies; Data Collection; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nonprescription Drugs; Prescription Drugs; Prevalence; Quinoxalines; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult

2011
Pharmacotherapy for smoking.
    Canadian family physician Medecin de famille canadien, 2011, Volume: 57, Issue:1

    Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2011
Integrating results from smoking cessation drug research and development into clinical occupational health practice.
    AAOHN journal : official journal of the American Association of Occupational Health Nurses, 2011, Volume: 59, Issue:2

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Occupational Health Nursing; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline

2011
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:2

    Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzazepines; Bupropion; DNA, Complementary; Dopamine Uptake Inhibitors; Electrophysiological Phenomena; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridinium Compounds; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus

2011
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
    Atencion primaria, 2011, Volume: 43, Issue:9

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Quinoxalines; Retrospective Studies; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult

2011
Prescribing of smoking cessation medication in England since the introduction of varenicline.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:7

    Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Time Factors; Varenicline

2011
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
    Archives of internal medicine, 2011, Apr-25, Volume: 171, Issue:8

    Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nasal Sprays; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; Treatment Outcome; Varenicline

2011
Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:9

    Topics: Adult; Benzazepines; Bupropion; Drug Utilization; England; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline

2011
Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:10

    Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; England; Epidemiologic Methods; Health Care Costs; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Wales

2011
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:10

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Female; Humans; Male; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Time Factors; Varenicline; Young Adult

2011
Smoking cessation pharmacotherapy: a concise overview.
    Advance for NPs & PAs, 2011, Volume: 2, Issue:4

    Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2011
Assessing preferences for improved smoking cessation medications: a discrete choice experiment.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2012, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Models, Econometric; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Switzerland; Varenicline; Young Adult

2012
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
    The Harvard mental health letter, 2011, Volume: 27, Issue:10

    Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; Varenicline

2011
Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
    Addiction (Abingdon, England), 2012, Volume: 107, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Policy; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Varenicline; Vietnam; Young Adult

2012
[Smoking cessation--assistance for the general practitioner].
    MMW Fortschritte der Medizin, 2011, Apr-07, Volume: 153, Issue:14

    Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2011
Suicidal behavior and depression in smoking cessation treatments.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline

2011
Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11.
    Addiction (Abingdon, England), 2012, Volume: 107, Issue:5

    Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Health Behavior; Humans; Longitudinal Studies; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2012
Real world evaluation of three models of NHS smoking cessation service in England.
    BMC research notes, 2012, Jan-06, Volume: 5

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Community Health Services; Counseling; England; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2012
Prescribing of nicotine replacement therapy to cardiovascular disease patients in England.
    Addiction (Abingdon, England), 2012, Volume: 107, Issue:7

    Topics: Adult; Benzazepines; Bupropion; Coronary Disease; Drug Prescriptions; England; General Practice; Humans; Nicotinic Agonists; Prescription Drugs; Quinoxalines; Regression Analysis; Smoking Cessation; Smoking Prevention; Stroke; Tobacco Use Cessation Devices; Varenicline

2012
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Hospital practice (1995), 2012, Volume: 40, Issue:1

    Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Central America; Cost-Benefit Analysis; Dominican Republic; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2012
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Hospital practice (1995), 2012, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Coronary Disease; Costs and Cost Analysis; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Middle Aged; Nicaragua; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Stroke; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult

2012
An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:1

    Topics: Administration, Inhalation; Adolescent; Adult; Aged; Benzazepines; Bupropion; Data Collection; Educational Status; Female; Humans; Internet; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult

2013
Promoting smoking cessation.
    American family physician, 2012, Mar-15, Volume: 85, Issue:6

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Complementary Therapies; Family Practice; Female; Health Promotion; Humans; Male; Motivation; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline

2012
Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:1

    Topics: Adult; Aged; Benzazepines; Bupropion; Female; Hospitalization; Humans; Male; Mental Disorders; Middle Aged; Military Personnel; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline; Young Adult

2013
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Clinical therapeutics, 2012, Volume: 34, Issue:8

    Topics: Benzazepines; Bupropion; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Greece; Health Care Costs; Humans; Insurance, Health, Reimbursement; Markov Chains; Models, Economic; Monte Carlo Method; Prevalence; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline

2012
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:1

    Topics: Adolescent; Adult; Age Distribution; Aged; Australia; Benzazepines; Bupropion; Canada; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult

2013
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
    Toxicology and applied pharmacology, 2012, Nov-15, Volume: 265, Issue:1

    Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Electron Transport; Gene Expression; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mitochondria; Nicotine; Nicotinic Agonists; Oxidative Stress; Pancreatic Function Tests; Quinoxalines; Rats; Signal Transduction; Smoking; Smoking Cessation; Varenicline

2012
Alpha oscillations in response to affective and cigarette-related stimuli in smokers.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:5

    Topics: Adult; Attention; Benzazepines; Brain; Bupropion; Cues; Demography; Electroencephalography Phase Synchronization; Emotions; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Photic Stimulation; Quinoxalines; Recurrence; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Products; Varenicline

2013
Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
    Current medicinal chemistry, 2012, Volume: 19, Issue:34

    Topics: Benzazepines; Bupropion; Chromosomes, Human, Pair 15; Genetic Loci; Genome-Wide Association Study; Humans; Multigene Family; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2012
Strategies to help a smoker who is struggling to quit.
    JAMA, 2012, Oct-17, Volume: 308, Issue:15

    Topics: Behavior Therapy; Benzazepines; Bupropion; Chronic Disease; Counseling; Disease Management; Dopamine Uptake Inhibitors; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Physician's Role; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2012
Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013, Volume: 15, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Brazil; Bupropion; Demography; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline

2013
[Methods and results of smoking cessation in cancer smoker's].
    Bulletin du cancer, 2012, Volume: 99, Issue:11

    Topics: Benzazepines; Bupropion; Humans; Neoplasms; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2012
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.
    BMJ (Clinical research ed.), 2012, Nov-08, Volume: 345

    Topics: Acute Coronary Syndrome; Adult; Age Distribution; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confidence Intervals; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Quinoxalines; Retrospective Studies; Risk Assessment; Sex Distribution; Smoking Cessation; Stroke; Survival Analysis; Varenicline

2012
Tracking dental patient tobacco use and intervention in the academic clinical setting.
    Journal of dental education, 2012, Volume: 76, Issue:11

    Topics: Age of Onset; Benzazepines; Bupropion; Counseling; Dental Records; Dopamine Uptake Inhibitors; Electronic Health Records; Female; Follow-Up Studies; Humans; Male; Medical History Taking; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Referral and Consultation; Schools, Dental; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Varenicline; West Virginia

2012
Varenicline and bupropion: suicide.
    Prescrire international, 2012, Volume: 21, Issue:131

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Patient Safety; Prescription Drug Misuse; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Suicide; Varenicline

2012
[Consensus report for the clinical care of smoking cessation in Spain. Comité Nacional para la Prevención del Tabaquismo].
    Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

    Topics: Benzazepines; Bupropion; Counseling; Humans; Motivation; Nicotinic Agonists; Patient Compliance; Patient Education as Topic; Persuasive Communication; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2013
Use of varenicline versus bupropion and risk of psychiatric adverse events.
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:7

    Topics: Adult; Benzazepines; Bupropion; Denmark; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Proportional Hazards Models; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline

2013
Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
    Mayo Clinic proceedings, 2013, Volume: 88, Issue:3

    Topics: Adult; Benzazepines; Bupropion; Comparative Effectiveness Research; Dopamine Uptake Inhibitors; Drug Therapy, Combination; England; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2013
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.
    JAMA internal medicine, 2013, May-13, Volume: 173, Issue:9

    Topics: Adult; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Risk Factors; Sentinel Surveillance; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline

2013
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
    Archivos de bronconeumologia, 2013, Volume: 49, Issue:8

    Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2013
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
    PharmacoEconomics, 2013, Volume: 31, Issue:9

    Topics: Adult; Benzazepines; Bupropion; Clinical Trials as Topic; Computer Simulation; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Quality of Life; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2013
[Results of a multidisciplinary program to quit smoking].
    Revista medica de Chile, 2013, Volume: 141, Issue:3

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Care Team; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult

2013
Varenicline, smoking cessation, and neuropsychiatric adverse events.
    The American journal of psychiatry, 2013, Volume: 170, Issue:12

    Topics: Adult; Aggression; Akathisia, Drug-Induced; Benzazepines; Bupropion; Depression; Female; Humans; Male; Mental Disorders; Nausea; Observational Studies as Topic; Psychomotor Agitation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Suicidal Ideation; Suicide, Attempted; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2013
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.
    BMJ (Clinical research ed.), 2013, Oct-11, Volume: 347

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Depression; England; Female; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; Varenicline; Young Adult

2013
Effect of allopurinol on smoking.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6

    Topics: Acetylcholine; Allopurinol; Benzazepines; Brain Chemistry; Bupropion; Causality; Comorbidity; Diabetic Nephropathies; Humans; Hypoxanthine; Molecular Structure; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Structure-Activity Relationship; Varenicline; Xanthine Oxidase

2013
Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.
    International journal of environmental research and public health, 2013, Dec-24, Volume: 11, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bipolar Disorder; Bupropion; Clinical Trials as Topic; Follow-Up Studies; Humans; Motivational Interviewing; Nicotinic Agonists; Psychotherapy, Group; Quinoxalines; Schizophrenic Psychology; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2013
'Real-world' effectiveness of smoking cessation treatments: a population study.
    Addiction (Abingdon, England), 2014, Volume: 109, Issue:3

    Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult

2014
[Safety of nicotine addiction treatment].
    Przeglad lekarski, 2013, Volume: 70, Issue:10

    Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia

2013
Tobacco quitline outcomes by service type.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2014, Volume: 67, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Longitudinal Studies; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; South Dakota; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult

2014
General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
    BMC family practice, 2014, Mar-20, Volume: 15

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Chronic Disease; Drug Therapy, Combination; Electronic Health Records; Female; General Practitioners; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Selection; Practice Patterns, Physicians'; Quinoxalines; Research Design; Retrospective Studies; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United Kingdom; Varenicline; Young Adult

2014
quit4u: the effectiveness of combining behavioural support, pharmacotherapy and financial incentives to support smoking cessation.
    Health education research, 2015, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Bupropion; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Motivation; Psychotherapy, Group; Scotland; Smoking Cessation; Socioeconomic Factors; State Medicine; Tobacco Use Cessation Devices; Varenicline; Young Adult

2015
Tobacco smoking: options for helping smokers to quit.
    Australian family physician, 2014, Volume: 43, Issue:6

    Topics: Australia; Benzazepines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; General Practice; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2014
[Abstinence rates among varenicline are highest].
    Medizinische Monatsschrift fur Pharmazeuten, 2014, Volume: 37, Issue:5

    Topics: Benzazepines; Bupropion; Humans; Mental Disorders; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline

2014
Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
    Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:11

    Topics: Aged; Aged, 80 and over; Benzazepines; Bupropion; Cardiovascular Diseases; Cohort Studies; Comorbidity; Female; Humans; Incidence; Male; Medicare; Nicotinic Agonists; Quinoxalines; Smoking Cessation; United States; Varenicline

2014
Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
    BMJ open, 2014, Aug-28, Volume: 4, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; General Practice; Humans; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline

2014
Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats.
    Behavioural pharmacology, 2014, Volume: 25, Issue:8

    Topics: Animals; Benzazepines; Bupropion; Cholinergic Agents; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Male; Naltrexone; Narcotic Antagonists; Nicotine; Quinoxalines; Rats; Rats, Long-Evans; Reinforcement, Psychology; Varenicline

2014
Emotional disorders and smoking: relations to quit attempts and cessation strategies among treatment-seeking smokers.
    Addictive behaviors, 2015, Volume: 40

    Topics: Adult; Anxiety Disorders; Benzazepines; Bupropion; Cross-Sectional Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult

2015
Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study.
    Addiction (Abingdon, England), 2015, Volume: 110, Issue:3

    Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult

2015
Maintenance of tobacco cessation programmes in public hospitals in Catalonia, Spain.
    Addictive behaviors, 2015, Volume: 42

    Topics: Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Hospitalization; Hospitals, Public; Humans; Inpatients; Nicotinic Agonists; Personnel, Hospital; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
Nationwide Smoking Cessation Treatment Support Program--Turkey project.
    Health policy (Amsterdam, Netherlands), 2015, Volume: 119, Issue:1

    Topics: Adult; Bupropion; Female; Health Policy; Humans; Male; Middle Aged; Program Evaluation; Smoking Cessation; Tobacco Use Cessation Devices; Turkey; Varenicline

2015
Providing medication therapy management for smoking cessation patients.
    Journal of pharmacy practice, 2015, Volume: 28, Issue:1

    Topics: Bupropion; Humans; Medication Adherence; Medication Therapy Management; Nicotinic Agonists; Professional Role; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline

2015
Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
    Respiratory medicine, 2015, Volume: 109, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Counseling; Denmark; Dopamine Uptake Inhibitors; Female; General Practice; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult

2015
Bupropion-varenicline interactions and nicotine self-administration behavior in rats.
    Pharmacology, biochemistry, and behavior, 2015, Volume: 130

    Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Drug Synergism; Female; Nicotine; Rats; Self Administration; Varenicline

2015
Higher Adherence During Reimbursement of Pharmacological Smoking Cessation Treatments.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2016, Volume: 18, Issue:1

    Topics: Adult; Bupropion; Counseling; Female; Humans; Insurance, Health, Reimbursement; Male; Medication Adherence; Middle Aged; Netherlands; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline

2016
Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report.
    Journal of medical case reports, 2015, Feb-13, Volume: 9

    Topics: Bupropion; Counseling; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline

2015
Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers.
    Drug and alcohol dependence, 2015, Sep-01, Volume: 154

    Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; United States; Varenicline; Young Adult

2015
Homeless Clients Benefit From Smoking Cessation Treatment Delivered by a Homeless Persons' Program.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2015, Volume: 17, Issue:8

    Topics: Bupropion; Community Health Nursing; Delivery of Health Care, Integrated; Female; Health Promotion; Humans; Ill-Housed Persons; Male; Middle Aged; Patient Acceptance of Health Care; Smoking Cessation; Surveys and Questionnaires; Telemedicine; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Victoria

2015
Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.
    Psychiatric services (Washington, D.C.), 2015, Volume: 66, Issue:11

    Topics: Bupropion; Counseling; Humans; Insurance Carriers; Insurance Coverage; Logistic Models; Medicaid; Multivariate Analysis; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline

2015
Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.
    Tobacco control, 2016, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Recurrence; Smokers; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult

2016
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.
    The Lancet. Respiratory medicine, 2015, Volume: 3, Issue:10

    Topics: Adult; Bupropion; Cardiovascular Diseases; Depression; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2015
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement.
    Annals of internal medicine, 2015, Oct-20, Volume: 163, Issue:8

    Topics: Adult; Behavior Therapy; Biomedical Research; Bupropion; Cost of Illness; Counseling; Electronic Nicotine Delivery Systems; Female; Humans; Nicotinic Agonists; Pregnancy; Risk Assessment; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline

2015
Summaries for Patients. Behavioral and Pharmacologic Treatments to Help Adults Quit Smoking: U.S. Preventive Services Task Force Recommendation Statement.
    Annals of internal medicine, 2015, Oct-20, Volume: 163, Issue:8

    Topics: Adult; Behavior Therapy; Bupropion; Counseling; Electronic Nicotine Delivery Systems; Female; Humans; Nicotinic Agonists; Pregnancy; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline

2015
Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey.
    Turkish journal of medical sciences, 2015, Volume: 45, Issue:4

    Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Turkey; Varenicline

2015
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.
    International journal of chronic obstructive pulmonary disease, 2015, Volume: 10

    Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Female; Health Care Costs; Health Expenditures; Humans; Male; Markov Chains; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Varenicline

2015
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers.
    Substance use & misuse, 2015, Volume: 50, Issue:13

    Topics: Adolescent; Adult; Aged; Bupropion; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 2; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Nicotinic Agonists; Obesity; Proportional Hazards Models; Retrospective Studies; Risk; Smoking; Smoking Cessation; Varenicline; Young Adult

2015
Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.
    Journal of hospital medicine, 2016, Volume: 11, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Admission; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; United States Department of Veterans Affairs; Varenicline

2016
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
    BMC cardiovascular disorders, 2016, Jan-05, Volume: 16

    Topics: Adult; Aged; Blood Pressure; Brazil; Bupropion; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Diastole; Dopamine Uptake Inhibitors; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Systole; Tobacco Use Cessation Devices; Varenicline

2016
[Varenicline in nicotine replacement therapy: Does it really increase the risk of cardiovascular and neuropsychiatric events?].
    Semergen, 2016, Volume: 42, Issue:6

    Topics: Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Varenicline

2016
Neighbourhood Deprivation and Outcomes of Stop Smoking Support--An Observational Study.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Adult; Bupropion; Female; Humans; Logistic Models; London; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Poverty; Residence Characteristics; Smoking; Smoking Cessation; Smoking Prevention; Social Class; Tobacco Use Cessation Devices; Varenicline

2016
Factors affecting dropout in the smoking cessation outpatient clinic.
    Chronic respiratory disease, 2016, Volume: 13, Issue:2

    Topics: Adult; Age Factors; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Educational Status; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Patient Dropouts; Retrospective Studies; Sex Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult

2016
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.
    Behavioural pharmacology, 2016, Volume: 27, Issue:2-3 Spec I

    Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Conditioning, Operant; Discrimination Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Macaca mulatta; Male; Methamphetamine; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Risperidone; Time Factors; Varenicline

2016
Drugs for smoking cessation.
    BMJ (Clinical research ed.), 2016, Feb-23, Volume: 352

    Topics: Bupropion; Contraindications; Dopamine Uptake Inhibitors; Drug Monitoring; Female; Humans; Middle Aged; Nicotinic Agonists; Practice Guidelines as Topic; Pregnancy; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2016
Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
    Addiction (Abingdon, England), 2016, Volume: 111, Issue:4

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline

2016
Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation.
    Substance use & misuse, 2016, Volume: 51, Issue:5

    Topics: Adult; Bupropion; Female; Humans; Male; Middle Aged; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Weight Gain

2016
Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany.
    Applied health economics and health policy, 2016, Volume: 14, Issue:4

    Topics: Adult; Aged; Bupropion; Cost-Benefit Analysis; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Financing, Personal; Germany; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult

2016
Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012.
    American journal of preventive medicine, 2016, Volume: 51, Issue:3

    Topics: Aged; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Medicare; Middle Aged; Nicotinic Agonists; Prescription Drugs; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline

2016
Safety of smoking cessation drugs for mentally ill patients.
    Lancet (London, England), 2016, Jun-18, Volume: 387, Issue:10037

    Topics: Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotinic Agonists; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline

2016
Effects of aging on the effectiveness of smoking cessation medication.
    Oncotarget, 2016, May-24, Volume: 7, Issue:21

    Topics: Adult; Age Factors; Aged; Brazil; Bupropion; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Precision Medicine; Smoking Cessation; Treatment Outcome; Varenicline

2016
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: Recommendation Statement.
    American family physician, 2016, May-15, Volume: 93, Issue:10

    Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Counseling; Electronic Nicotine Delivery Systems; Female; Health Plan Implementation; Humans; Male; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking Prevention; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline

2016
The use of varenicline to treat nicotine dependence among patients with cancer.
    Psycho-oncology, 2017, Volume: 26, Issue:10

    Topics: Adult; Benzazepines; Bupropion; Counseling; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2017
Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months.
    Nagoya journal of medical science, 2016, Volume: 78, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bupropion; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Varenicline

2016
A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.
    AIDS and behavior, 2017, Volume: 21, Issue:7

    Topics: Adult; Algorithms; Antidepressive Agents, Second-Generation; Black or African American; Bupropion; Counseling; Female; HIV Infections; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; White People

2017
Guidelines for the Treatment of Smoking in Hospitalized Patients.
    Archivos de bronconeumologia, 2017, Volume: 53, Issue:7

    Topics: Bupropion; Clinical Trials as Topic; Comorbidity; Counseling; Evidence-Based Medicine; Humans; Inpatients; Meta-Analysis as Topic; Motivation; Practice Guidelines as Topic; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Varenicline

2017
The Adverse Effects and Treatment Results of Smoking Cessation Pharmacotherapy During Fasting/Non-Fasting State.
    Substance use & misuse, 2017, 07-03, Volume: 52, Issue:8

    Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Fasting; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2017
Medicaid Coverage of Smoking Cessation Counseling and Medication Is Underutilized for Pregnant Women.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2017, May-01, Volume: 19, Issue:5

    Topics: Adult; Bupropion; Counseling; Databases, Factual; Dopamine Uptake Inhibitors; Female; Humans; Insurance Coverage; Kansas; Medicaid; Nicotinic Agonists; Poverty; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline; Young Adult

2017
Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease.
    Thorax, 2017, Volume: 72, Issue:10

    Topics: Adult; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Propensity Score; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2017
Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
    Archivos de bronconeumologia, 2017, Volume: 53, Issue:11

    Topics: Biomarkers; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Counseling; Evidence-Based Medicine; Humans; Motivation; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline

2017
Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2018, 04-02, Volume: 20, Issue:5

    Topics: Accidental Falls; Accidents, Traffic; Adult; Bupropion; Cardiovascular Diseases; Cross-Over Studies; Humans; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Suicide, Attempted; Sweden; Tobacco Use Disorder; Varenicline; Wounds and Injuries

2018
Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.
    Drug and alcohol dependence, 2017, 08-01, Volume: 177

    Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Drug Labeling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration; Varenicline; Young Adult

2017
[Design and user-testing of a decision aid comparing medications for smoking cessation].
    Revue medicale suisse, 2017, Jun-07, Volume: 13, Issue:566

    Topics: Bupropion; Decision Support Techniques; Humans; Patient Preference; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline

2017
Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice.
    JAMA cardiology, 2017, 09-01, Volume: 2, Issue:9

    Topics: Age Factors; Aged; Bupropion; Comorbidity; Female; Humans; Lung Diseases; Male; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Peripheral Arterial Disease; Secondary Prevention; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Varenicline

2017
Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
    European psychiatry : the journal of the Association of European Psychiatrists, 2017, Volume: 45

    Topics: Bupropion; Cost-Benefit Analysis; Depressive Disorder, Major; Female; Health Care Costs; Humans; Male; Markov Chains; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2017
Use of prescribed smoking cessation pharmacotherapy following release from prison: a prospective data linkage study.
    Tobacco control, 2018, Volume: 27, Issue:4

    Topics: Adult; Age Factors; Australia; Bupropion; Female; Humans; Information Storage and Retrieval; Male; Patient Acceptance of Health Care; Prisoners; Prospective Studies; Risk Factors; Smoking; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult

2018
In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT.
    Annals of internal medicine, 2017, 09-19, Volume: 167, Issue:6

    Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2017
Evaluation of smoking cessation intervention in patients with chronic diseases in smoking cessation clinics.
    Medicine, 2017, Volume: 96, Issue:42

    Topics: Adult; Bupropion; Chronic Disease; Combined Modality Therapy; Counseling; Follow-Up Studies; Humans; Intention to Treat Analysis; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2017
Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
    Scientific reports, 2017, 12-01, Volume: 7, Issue:1

    Topics: 5' Untranslated Regions; Adult; Aged; Bupropion; Carbon Monoxide; Exhalation; Female; Humans; Male; Middle Aged; Nerve Tissue Proteins; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult

2017
[Clinical Practice Guidelines for Smoking Cessation].
    Revista medica de Chile, 2017, Volume: 145, Issue:11

    Topics: Bupropion; Chile; Evidence-Based Medicine; Humans; Nicotine; Smoking Cessation; Varenicline

2017
Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study.
    International journal of chronic obstructive pulmonary disease, 2018, Volume: 13

    Topics: Adult; Age Factors; Aged; Bupropion; Denmark; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Regression Analysis; Sex Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Socioeconomic Factors; Varenicline

2018
Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2020, 04-17, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Health Behavior; Humans; Male; Middle Aged; Nicotinic Agonists; Ontario; Pharmaceutic Aids; Smokers; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult

2020
Cost-utility analysis of smoking cessation to prevent operative complications following elective abdominal colon surgery.
    American journal of surgery, 2018, Volume: 216, Issue:6

    Topics: Bupropion; Colectomy; Cost-Benefit Analysis; Decision Trees; Elective Surgical Procedures; Health Care Costs; Humans; Postoperative Complications; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline

2018
Which Types of Tobacco Treatment Interventions Work for People with Schizophrenia? Provider and Mental Health Consumer Perspectives.
    Issues in mental health nursing, 2019, Volume: 40, Issue:10

    Topics: Adult; Attitude of Health Personnel; Behavior Therapy; Bupropion; Counseling; Female; Health Education; Health Promotion; Health Services Needs and Demand; Humans; Interview, Psychological; Male; Middle Aged; Patient Acceptance of Health Care; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Social Support; Treatment Outcome; United States; Varenicline; Young Adult

2019
Individual differences in responding to bupropion or varenicline in a preclinical model of nicotine self-administration vary according to individual demand for nicotine.
    Neuropharmacology, 2019, Volume: 148

    Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Extinction, Psychological; Individuality; Male; Nicotine; Rats; Reinforcement Schedule; Self Administration; Sucrose; Varenicline

2019
Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
    JAMA, 2019, Feb-12, Volume: 321, Issue:6

    Topics: Behavior Therapy; Bupropion; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United States; Varenicline

2019
Cost-effectiveness of real-world administration of tobacco pharmacotherapy in the United States Veterans Health Administration.
    Addiction (Abingdon, England), 2019, Volume: 114, Issue:8

    Topics: Adult; Aged; Bupropion; Cohort Studies; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Retrospective Studies; Smoking Cessation Agents; Tobacco Use; Tobacco Use Cessation; Tobacco Use Cessation Devices; United States; United States Department of Veterans Affairs; Varenicline; Veterans Health

2019
Moderators of real-world effectiveness of smoking cessation aids: a population study.
    Addiction (Abingdon, England), 2019, Volume: 114, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Bupropion; Counseling; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Female; Humans; Hypnosis; Internet; Male; Middle Aged; Nonprescription Drugs; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Social Class; Surveys and Questionnaires; Telephone; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult

2019
Predictors of long-term abstinence rate by income level in the Korean smoking cessation programme.
    Addiction (Abingdon, England), 2019, Volume: 114, Issue:11

    Topics: Adult; Bupropion; Female; Humans; Income; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Republic of Korea; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline

2019
Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats.
    Addiction biology, 2020, Volume: 25, Issue:5

    Topics: Alcohol-Related Disorders; Animals; Bupropion; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Male; Nucleus Accumbens; Rats; Rats, Wistar; Smoking Cessation Agents; Varenicline

2020
Estimation of high-dimensional propensity scores with multiple exposure levels.
    Pharmacoepidemiology and drug safety, 2020, Volume: 29 Suppl 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bupropion; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Pharmacoepidemiology; Propensity Score; Proportional Hazards Models; Retrospective Studies; Smoking Cessation; United Kingdom; Varenicline; Young Adult

2020
Health-care providers' concern regarding smoking cessation pharmacotherapies during pregnancy: Calls to a teratology information service.
    Drug and alcohol review, 2020, Volume: 39, Issue:3

    Topics: Australia; Behavior Therapy; Bupropion; Call Centers; Female; Health Personnel; Humans; Information Services; Nicotine; Pregnancy; Smoking; Smoking Cessation; Teratology; Tobacco Use Cessation Devices; Varenicline

2020
Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019.
    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2020, Jan-30, Volume: 26, Issue:1

    Topics: Africa, Northern; Bupropion; Health Services Accessibility; Humans; Middle East; Primary Health Care; Smoking Cessation; Smoking Cessation Agents; Varenicline

2020
Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.
    Addiction (Abingdon, England), 2020, Volume: 115, Issue:8

    Topics: Adolescent; Adult; Aged; Bupropion; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult

2020
Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats.
    Behavioural brain research, 2020, 05-15, Volume: 385

    Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; Bupropion; Conditioning, Psychological; Economics, Behavioral; Extinction, Psychological; Female; Individuality; Nicotine; Nicotinic Agonists; Rats; Self Administration; Smoking Cessation Agents; Varenicline; Yohimbine

2020
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
    PloS one, 2020, Volume: 15, Issue:3

    Topics: Adult; Bupropion; Crohn Disease; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Pilot Projects; Prevalence; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline

2020
Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
    Current drug safety, 2020, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Bupropion; Female; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacovigilance; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration; Varenicline; Young Adult

2020
[Influencing factors on smoking cessation among outpatients from the National Central Subsidy Smoking Cessation Clinic Project, in 2015-2018].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2020, Jun-10, Volume: 41, Issue:6

    Topics: Bupropion; China; Follow-Up Studies; Humans; Outpatients; Program Evaluation; Smoking Cessation; Surveys and Questionnaires; Varenicline

2020
The Persistent Challenge of Developing Addiction Pharmacotherapies.
    Cold Spring Harbor perspectives in medicine, 2021, 11-01, Volume: 11, Issue:11

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Drug Therapy; Humans; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Smoking Cessation Agents; Substance-Related Disorders; Varenicline

2021
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.
    American journal of respiratory and critical care medicine, 2020, 07-15, Volume: 202, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bupropion; Female; Humans; Male; Middle Aged; Practice Guidelines as Topic; Smoking Cessation Agents; Tobacco Use Disorder; United States; Varenicline

2020
Essential tobacco dependence medicines in 137 countries.
    Addiction (Abingdon, England), 2021, Volume: 116, Issue:6

    Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2021
Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.
    Addiction (Abingdon, England), 2021, Volume: 116, Issue:6

    Topics: Adult; Aged; Benzazepines; Bupropion; Cross-Over Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Self-Injurious Behavior; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; United Kingdom; Varenicline

2021
Commentary on Thomas et al.: Are simple solutions to complex problems possible?
    Addiction (Abingdon, England), 2021, Volume: 116, Issue:6

    Topics: Bupropion; Cross-Over Studies; Humans; Smoking Cessation; Tobacco Use Cessation Devices; United Kingdom; Varenicline

2021
Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting.
    BMJ open, 2021, 05-25, Volume: 11, Issue:5

    Topics: Benzazepines; Bupropion; Cohort Studies; Humans; Netherlands; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2021
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis.
    Pharmacoepidemiology and drug safety, 2022, Volume: 31, Issue:2

    Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Varenicline

2022
Cost-effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world.
    Pharmacoepidemiology and drug safety, 2022, Volume: 31, Issue:2

    Topics: Adult; Bupropion; Cost-Benefit Analysis; Humans; Male; Retrospective Studies; Smoking Cessation; Tobacco Use Disorder; Varenicline

2022
Bupropion for smoking cessation in adolescents.
    Canadian family physician Medecin de famille canadien, 2021, Volume: 67, Issue:10

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline

2021
Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
    JAMA network open, 2021, 11-01, Volume: 4, Issue:11

    Topics: Adult; Bupropion; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; New South Wales; Retrospective Studies; Smoking; Smoking Cessation Agents; Varenicline

2021
Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
    Addiction (Abingdon, England), 2022, Volume: 117, Issue:10

    Topics: Aged; Australia; Benzazepines; Bupropion; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2022
The 2022 Ferno Award Address: CrEATE, an Efficient Crossover Evaluation of Addiction Treatment Efficacy.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 01-01, Volume: 25, Issue:1

    Topics: Benzazepines; Bupropion; Cross-Over Studies; Humans; Nicotinic Agonists; Smoking; Treatment Outcome; Varenicline

2023
[Tobacco cessation treatment for people with schizophrenia].
    Revue medicale suisse, 2022, Jun-22, Volume: 18, Issue:787

    Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline

2022
Abstinence Rate, Adverse Events and Withdrawal Symptoms after Varenicline Use and Predicting Factors of Smoking Abstinence: A Multicentre Single-State Study in Malaysia.
    International journal of environmental research and public health, 2022, 06-24, Volume: 19, Issue:13

    Topics: Adolescent; Adult; Benzazepines; Bupropion; Cohort Studies; Humans; Malaysia; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline

2022
Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2022, 11-12, Volume: 24, Issue:12

    Topics: Adult; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2022
Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.
    Drug and alcohol review, 2023, Volume: 42, Issue:1

    Topics: Bupropion; COVID-19; Humans; Interrupted Time Series Analysis; Nicotine; Nicotinic Agonists; Pandemics; Pharmaceutical Preparations; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2023
Smoking Cessation Medication Prescribing for Smokers With and Without Mental Illness.
    Psychiatric services (Washington, D.C.), 2023, 04-01, Volume: 74, Issue:4

    Topics: Bupropion; Humans; Nicotinic Agonists; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2023
Smoking Cessation Interventions.
    American family physician, 2022, Volume: 106, Issue:5

    Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult

2022
Varenicline serves as the training stimulus in the drug-discriminated goal-tracking task with rats: initial evaluation of potential neuropharmacological processes.
    Behavioural pharmacology, 2023, 02-01, Volume: 34, Issue:1

    Topics: Animals; Benzazepines; Bupropion; Goals; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Smoking Cessation Agents; Varenicline

2023
How do patients and staff in an opioid agonist treatment service view smoking cessation medications and e-cigarettes?
    Drug and alcohol review, 2023, Volume: 42, Issue:5

    Topics: Analgesics, Opioid; Australia; Bupropion; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline

2023
Smoking cessation and vaccination.
    European respiratory review : an official journal of the European Respiratory Society, 2023, Mar-31, Volume: 32, Issue:167

    Topics: Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Vaccination; Varenicline

2023
The utility of the self-controlled study design for pharmacoepidemiological studies without an active comparator medication using a medical information database: An application to assess the risk of varenicline on cardiovascular outcomes.
    Pharmacoepidemiology and drug safety, 2023, Volume: 32, Issue:10

    Topics: Adult; Bupropion; Cohort Studies; Humans; Male; Proportional Hazards Models; Smoking Cessation; Varenicline

2023
Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy.
    BMC medical research methodology, 2023, 04-29, Volume: 23, Issue:1

    Topics: Bayes Theorem; Bupropion; Humans; Smoking; Smoking Cessation; Varenicline

2023
Behavioral therapy and pharmacotherapy: A case report on right approach for tobacco cessation.
    Journal of cancer research and therapeutics, 2023, Volume: 19, Issue:Supplement

    Topics: Aged, 80 and over; Behavior Therapy; Bupropion; Humans; Male; Smoking Cessation; Tobacco Use Cessation; Varenicline

2023
Initiation of Varenicline in People Hospitalized for Acute Coronary Syndrome Who Smoke.
    Circulation, 2023, 06-20, Volume: 147, Issue:25

    Topics: Acute Coronary Syndrome; Benzazepines; Bupropion; Cognition; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline

2023